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ABSTRACT
Halogenated methanes are among the most frequently encountered contaminants 
at hazardous waste sites. One such site in California is contaminated with chloroform 
(CF), carbon tetrachloride (CT), and trichlorofluoromethane (CFC-11). CF, CT and CFC-
11 are the main focus of this research; they are present at the California site at 
concentrations in the mg per liter range and a plume of contaminated groundwater 
emanating from a source zone is approaching a property boundary, necessitating 
remediation. Anaerobic bioremediation is one of the technologies under consideration for 
addressing the source zone and the less concentrated downgradient plume. A microcosm 
study was performed to evaluate natural attenuation, biostimulation and bioaugmentation. 
Treatment approaches using abiotic processes such as zero valent iron (ZVI), followed by 
bioremediation, were evaluated in additional experiments. 
The first objective of this laboratory study was to determine the effectiveness of 
biostimulation at removing halogenated methanes in the downgradient and upgradient 
locations.  Three types of electron donors were tested; two relatively fast acting (corn 
syrup and lactate) and one longer lasting (Slow Release Substrate (SRSTM), from Terra 
Systems).  The effect of cyanocobalamin (B12) was also evaluated with corn syrup, since 
the benefits of adding B12 are better documented with corn syrup versus lactate.  Addition 
of B12 was also be evaluated with SRS™, to determine if the same advantages observed 
with corn syrup can be achieved with a longer-lasting electron donor.  For each location, 
the concentration of major competing electron acceptors (e.g., nitrate and sulfate) was 
monitored.   
ii 
The second objective was to determine the effectiveness of bioaugmentation for 
improving the biodegradation rate for halogenated methanes in the downgradient and 
upgradient locations.  KB-1© Plus (containing the required mixture of Dehalobacter spp.) 
was evaluated for the downgradient and upgradient locations, while DHM-1 was tested 
with only the higher concentration upgradient location.  KB-1© Plus is advantageous 
from the perspective that it does not require B12 and the downgradient location has low 
concentrations of potentially inhibitory compounds (e.g., CT).  On the other hand, the 
upgradient location was more likely to have inhibitory compounds and a prior study 
indicated DHM-1 can be effective in that type of environment. 
The third objective was to determine the effectiveness of pH adjustment for 
accomplishing biostimulation and bioaugmentation at the downgradient location.  Since 
groundwater at the downgradient location has a pH greater than 6, bioremediation may be 
feasible without pH adjustment, although the buffering capacity in this area is not well 
established.  All treatments for the upgradient location were pH-adjusted, since the 
current pH is already below 6 and dechlorination of higher concentrations of CF will 
drive the pH even lower.  Sodium bicarbonate was used for pH adjustment. 
The fourth objective was to determine the effectiveness of abiotic and combined 
abiotic/biotic processes for treating the upgradient location.  These processes included 
ZVI followed by bioaugmentation with KB-1© Plus, sodium dithionite, calcium 
polysulfide, and a combination of titanium(III) citrate + B12 + corn syrup. 
The final objective of this study was to perform a mass balance for CF during 
biodegradation by the KB-1© Plus culture, using 14C-CF.  Although previous studies have 
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suggested that the end products are non-hazardous, a complete mass balance to confirm 
this has not yet been performed.   
For objectives 1 through 4, five sets of microcosms (i.e., Sets I through V) were 
prepared with soil and groundwater from the industrial site.  For objective 5, only the 
KB-1© Plus culture was used.  Based on results from the microcosms, all of the donor-
amended treatments removed CT, in the low and high concentration microcosms. 
Although the rates differed, removal of CT occurred consistently and is not a major factor 
in selection of a bioremediation strategy.   
For the downgradient portion of the plume, the most effective bioremediation 
strategy for CF and dichloromethane (DCM) is bioaugmentation with KB-1© Plus 
amended with lactate.  pH control does not appear to be necessary; the no pH control (Set 
II) and microcosms with pH control (Set III) performed similarly.  Somewhat unexpected
was the robust performance of the pH adjusted microcosms that received lactate as an 
electron donor.  These results suggest that the site contains indigenous Dehalobacter spp. 
that are capable of organohalide respiration of CF to DCM and fermentation of DCM to 
nonchlorinated products.  Although bioaugmentation with KB-1© Plus amended with 
lactate was effective for CF and DCM in the downgradient portion of the plume, CFC-11 
persisted until most of the CF was consumed, at which point a relatively fast reduction to 
CHCl2F occurred.   
For the upgradient portion of the plume, the most effective bioremediation 
strategy for CF and DCM is bioaugmentation with DHM-1 amended with SRS and B12.  
This treatment achieved complete removal of CF and significant removal of CFC-11 and 
iv 
DCM. Removal of the DCM suggests that the site contains an indigenous population of
anaerobic microbes capable of fermenting DCM as a sole substrate.  Bioaugmentation 
with the KB-1© Plus amended with lactate also showed promise for the upgradient zone, 
although additional incubation is needed to confirm consumption of DCM formed from 
CF.  Also, KB-1© Plus was less effective in removing CFC-11; follow-up 
bioaugmentation with DHM-1 should be feasible to address the CFC-11.   
The high level of sulfate in the downgradient and upgradient groundwater created 
a high demand for electron donor.  Significant improvement in the rate of CFC-11, CF, 
and DCM biodegradation ensued following an increase in the frequency and amount of 
electron donor additions after 300 days of incubation, commensurate with the onset of 
sulfate reduction.  This lag could have been shortened significantly by following a much 
more aggressive schedule of electron donor additions earlier in the incubation period.  
Lactate and corn syrup were more effective in establishing sulfate reducing conditions 
than SRS.  It is likely that the initially slow rate of electron donor additions resulted in 
wasteful additions of bioaugmentation culture and B12; these additions should have been 
made only after sulfate reduction was well established.  The sulfide generated from 
sulfate reduction likely created the low redox conditions that are conducive to 
halomethane degradation. 
The most effective abiotic treatment involved the use of ZVI; after approximately 
three months of incubation, the CT, CF, and CFC-11 were removed.  However, DCM and 
CHCl2F persisted; an attempt to biodegrade DCM by augmenting with KB-1© Plus was 
ineffective, for reasons that are not yet known.  Also, unknown volatile compounds 
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accumulated in the ZVI-amended microcosms.  While ZVI was faster than the biotic 
treatments in this study, this advantage would likely diminish if the biotic-only treatments 
had received more aggressive additions of electron donor from the outset;. 
Using 14C-CF, it was shown that the principal product from anaerobic 
biodegradation of CF by KB-1© Plus is CO2.  This is the first report to demonstrate a 
complete mass balance on the products from CF biodegradation by KB-1© Plus, and to 
show that these products are nonhazardous.  CO2 accumulated in treatments with and 
without 2-bromoethanesulfonate added (to inhibit methanogenesis), and significant 
amounts accumulated even when CF was consumed but some DCM remained.  This 
suggests that the pathway for DCM metabolism in the KB-1© Plus culture is different 
from that reported for Dehalobacterium formicoaceticum, which directly incorporates the 
carbon in DCM into formate and acetate.  The disposition of reducing equivalents gained 
during fermentation of DCM is not yet known, although a preliminary experiment 
confirmed that hydrogen accumulates transiently as DCM is consumed.  It seems likely 
that the reducing equivalents formed from DCM are consumed for methane production 
and/or organic acid formation.  These products are not 14C-labeled most likely because 
the 14CO2 that is generated enters a large pool of bicarbonate in the mineral medium, such 
that any bicarbonate used for methane or organic acid formation has a low percentage of 
labeled compound (i.e., the 14CO2 is diluted out). 
vi 
ACKNOWLEDGEMENTS  
I wish to express my thankfulness to Dr. David L. Freedman for his advice, 
patience, and encouragement in two year of my pursuit for Master degree. Also I would 
like to acknowledge my other two committee members, Dr. Kevin T. Finneran, Dr. 
Elizabeth Carraway, and Dr. Cindy Lee for proxy of Dr. Elizabeth Carraway in my thesis 
defense.  
I gratefully acknowledge Rong Yu for her help on initiation of DHM-1 culture, 
radioactive isotope analysis; and Jin Guo for help on elemental experimental skills. I shall 
thank my lab mates during my time at Clemson University, i.e. Rong Yu, Jin Guo, 
Alejandro Ramos, Francisco Barajas, Rui Xiao, Benjamin Rihner, Paola Barreto, Kristin 
Frederickson, et al. for making the environment in our lab friendly and collaborative.  
And I am always thankful to my parents in China, Songchun Wang and Yanyan 
Wu, for their boundless love and endless support. 
vii 
TABLE OF CONTENTS 
           Page 
TITLE PAGE ....................................................................................................................... i 
ABSTRACT ....................................................................................................................... ii 
ACKNOWLEDGEMENTS .............................................................................................. vii 
LIST OF TABLES ...............................................................................................................x 
LIST OF FIGURES ........................................................................................................... xi 
ABBREVIATIONS ......................................................................................................... xvi 
1.0 INTRODUCTION AND OBJECTIVES ....................................................................1 
1.1 Anaerobic Cometabolic Biodegradation of CF......................................................... 2 
1.2 Anaerobic Metabolic Biodegradation of CF and DCM ............................................ 4 
1.3 Anaerobic Abiotic/Biotic Dehalogenation ................................................................ 8 
1.4 Objectives ............................................................................................................... 10 
2.0 MATERIALS AND METHODS ...............................................................................12 
2.1 Chemicals and Medium .......................................................................................... 12 
2.2 Sources for the Bioaugmentation Cultures ............................................................. 13 
2.3 Sample Locations and Conditions .......................................................................... 13 
2.4 Experimental Design for Microcosms .................................................................... 14 
2.4.1 Low-to-Medium Concentration Biotic-Only Microcosms .............................. 14 
2.4.2 High Concentration Biotic-Only Microcosms ................................................. 16 
2.4.3 High Concentration Abiotic/Biotic Microcosms ............................................. 17 
2.5 Products from Biodegradation of CF by KB-1© Plus ............................................. 18 
2.5.1 Set I .................................................................................................................. 18 
2.5.2 Set II ................................................................................................................. 19 
2.5.3 Set III ............................................................................................................... 19 
2.6 Microcosm Preparation ........................................................................................... 20 
2.7 Analytical Methods ................................................................................................. 21 
2.7.1 Volatile Organic Compound (VOC) Analysis ................................................. 21 
2.7.2 pH Measurement and Adjustment ................................................................... 22 
2.7.3 Organic Acids .................................................................................................. 22 
2.7.4 Nitrate and Sulfate ........................................................................................... 23 
2.7.5 14C Methods ..................................................................................................... 23 
3.0 RESULTS ...................................................................................................................26 
3.1 Low Concentration Biotic Microcosms .................................................................. 26 
3.1.1 Controls (Set I) ................................................................................................. 26 
3.1.2 Live, No pH Adjustment (Set II) ..................................................................... 26 
3.1.3 Live, pH Adjusted (Set III) .............................................................................. 30 
viii 
Table of Contents (Continued) Page 
3.2 High Concentration Biotic Microcosms ................................................................. 34 
3.2.1 Controls (Set IV) .............................................................................................. 34 
3.2.2 Live, pH Adjusted (Set V) ............................................................................... 34 
3.2.3 Overall Summary of Biotic Microcosm Performance ..................................... 38 
3.3 High Concentration Abiotic/Biotic Microcosms .................................................... 39 
3.4 CF Biodegradation Products from KB-1© Plus ...................................................... 40 
4.0 DISCUSSION .............................................................................................................43 




Appendix A ................................................................................................................ 102 
Appendix B ................................................................................................................ 104 
Appendix C ................................................................................................................ 110 
Appendix D ................................................................................................................ 112 
Appendix E ................................................................................................................ 114 
REFERENCES ................................................................................................................118 
ix 
LIST OF TABLES 
Table Page 
Table 2.1 Experimental design for Sets I through V microcosms .................................... 54 
Table 3.1 Summary of results for Sets I through V microcosms ...................................... 55 
Table 3.2 Summary of electron donor, B12, and bioaugmentation culture for Sets II, III, 
and V microcosms ....................................................................................... 56 
x 
LIST OF FIGURES 
Figure Page 
Figure 1.1 Pathways for anaerobic biodegradation of CF and DCM. Metabolic processes 
are indicated by solid lines; cometabolic pathways are indicated by dashed 
lines. Reductive dechlorination of CF to DCM may occu metabolically or 
cometabolically. [H] = H+ + e-. .................................................................. 58 
Figure 3.1 Results for Set I water control microcosms (WC); a) bottle #1; b) bottle #2; 
and c) bottle #3........................................................................................... 59 
Figure 3.2 Results for Set I autoclaved control microcosms (AC); a) bottle #1; b) bottle 
#2; and c) bottle #3. ................................................................................... 60 
Figure 3.3 Results for Set II unamended microcosms (UN); a) bottle #1; b) bottle #2; and 
c) bottle #3. ................................................................................................ 61 
Figure 3.4 Results for Set II microcosms (LAC) amended with lactate (indicated by 
arrows); a) bottle #1; b) bottle #2; and c) bottle #3. .................................. 62 
Figure 3.5 Results for Set II microcosms (CS) amended with corn syrup (indicated by 
arrows); a) bottle #1; b) bottle #2; and c) bottle #3. .................................. 63 
Figure 3.6 Results for Set II microcosms (CS+B12) amended with corn syrup (indicated 
by arrows) and B12 (red diamonds); a) bottle #1; b) bottle #2; and c) bottle 
#3................................................................................................................ 64 
Figure 3.7 Results for Set II microcosms (SRS) amended with vegetable oil (indicated by 
arrows); a) bottle #1; b) bottle #2; and c) bottle #3. .................................. 65 
Figure 3.8 Results for Set II microcosms (SRS+B12) amended with vegetable oil 
(indicated by arrows) and B12 (red diamonds); a) bottle #1; b) bottle #2; 
and c) bottle #3........................................................................................... 66 
Figure 3.9 Results for Set II microcosms (BA/A-LAC) amended with lactate (indicated 
by arrows), B12 (red diamond), and bioaugmented with KB-1© Plus (blue 
diamonds) and DHM-1 (green diamond); a) bottle #1; b) bottle #2; and c) 
bottle #3. .................................................................................................... 67 
Figure 3.10 Results for Set II microcosms (BA/A-SRS) amended with vegetable oil 
(indicated by arrows). B12 (red diamond), and bioaugmented with KB-1© 
Plus (blue diamonds) and DHM-1 (green diamond); a) bottle #1; b) bottle 
#2; and c) bottle #3. ................................................................................... 68 
xi 
List of Figures (Continued) Page 
Figure 3.11 Sulfate and volatile fatty acids (VFAs) analysis for Set II microcosms; a) 
sulfate concentrations for three different incubation days in representative 
bottles; b) VFAs and sulfate reudction (presented in mg COD/L) following 
476 days of incubation in representative bottles; halogenated methanes 
transformation controbited less than 0.2 % to COD utilization. ................ 69 
Figure 3.12 Results for Set III unamended microcosms (UN); a) bottle #1; b) bottle #2; 
and c) bottle #3........................................................................................... 70 
Figure 3.13 Results for Set III microcosms (LAC) amended with lactate (indicated by 
arrows); a) bottle #1; b) bottle #2; and c) bottle #3. .................................. 71 
Figure 3.14 Results for Set III microcosms (CS) amended with corn syrup (indicated by 
arrows) and NaHCO3 for pH adjustment (orange squares); a) bottle #1; b) 
bottle #2; and c) bottle #3. ......................................................................... 72 
Figure 3.15 Results for Set III microcosms (CS+B12) amended with corn syrup (indicated 
by arrows), B12 (red diamonds), and NaHCO3 for pH adjustment (orange 
squares); a) bottle #1; b) bottle #2; and c) bottle #3. ................................. 73 
Figure 3.16 Results for Set III microcosms (SRS) amended with vegetable oil (indicated 
by arrows) and NaHCO3 for pH adjustment (orange squares); a) bottle #1; 
b) bottle #2; and c) bottle #3. ..................................................................... 74 
Figure 3.17 Results for Set III microcosms (SRS+B12) amended with vegetable oil 
(indicated by arrows) and B12 (red diamonds); a) bottle #1; b) bottle #2; 
and c) bottle #3........................................................................................... 75 
Figure 3.18 Results for Set III microcosms (BA/A-LAC) amended with lactate (indicated 
by arrows), B12 (red diamond), and bioaugmented with KB-1© Plus (blue 
diamonds) and DHM-1 (green diamond); a) bottle #1; b) bottle #2; and c) 
bottle #3 ..................................................................................................... 76 
Figure 3.19  Results for Set III microcosms (BA/A-SRS) amended with vegetable oil 
(indicated by arrows), B12 (red diamond), NaHCO3 for pH adjustment 
(orange square), and bioaugmented with KB-1© Plus (blue diamonds) and 
DHM-1 (green diamond); a) bottle #1; b) bottle #2; and c) bottle #3 ....... 77 
Figure 3.20  Sulfate and volatile fatty acids (VFAs) analysis for Set III microcosms; a) 
sulfate concentrations for three different incubation days in representative 
bottles; b) VFAs and sulfate reudction (presented in mg COD/L) following 
476 days of incubation in representative bottles; halogenated methanes 
transformation controbited less than 0.05 % to COD utilization ............... 78 
xii 
List of Figures (Continued)                                                                                                Page 
Figure 3.21 Results for Set IV water control microcosms (WC); a) bottle #1; b) bottle #2; 
and c) bottle #3 .......................................................................................... 79 
Figure 3.22 Results for Set IV autoclaved control microcosms (AC); a) bottle #1; b) 
bottle #2; and c) bottle #3 .......................................................................... 80 
Figure 3.23 Results for Set V unamended microcosms (UN); a) bottle #1; b) bottle #2; 
and c) bottle #3. ......................................................................................... 81 
Figure 3.24 Results for Set V microcosms (LAC) amended with lactate (indicated by 
arrows); a) bottle #1; b) bottle #2; and c) bottle #3. .................................. 82 
Figure 3.25 Results for Set V microcosms (CS) amended with corn syrup (indicated by 
arrows) and NaHCO3 for pH adjustment (orange squares); a) bottle #1; b) 
bottle #2; and c) bottle #3. ......................................................................... 83 
Figure 3.26 Results for Set V microcosms (CS+B12) amended with corn syrup (indicated 
by arrows), B12 (red diamonds), and NaHCO3 for pH adjustment (orange 
squares); a) bottle #1; b) bottle #2; and c) bottle #3. ................................. 84 
Figure 3.27 Results for Set V microcosms (SRS) amended with vegetable oil (indicated 
by arrows) and NaHCO3 for pH adjustment (orange squares); a) bottle #1; 
b) bottle #2; and c) bottle #3. ..................................................................... 85 
Figure 3.28 Results for Set V microcosms (SRS+B12) amended with vegetable oil 
(indicated by arrows), B12 (red diamonds), and NaHCO3 for pH adjustment 
(orange squares); a) bottle #1; b) bottle #2; and c) bottle #3..................... 86 
Figure 3.29 Results for Set V microcosms (BA/A-LAC) amended with lactate (indicated 
by arrows), B12 (red diamond), and bioaugmented with KB-1© Plus (blue 
diamonds); a) bottle #1; b) bottle #2; and c) bottle #3 .............................. 87 
Figure 3.30  Results for Set V microcosms (BA/A-SRS) amended with vegetable oil 
(indicated by arrows), NaHCO3 for pH adjustment (orange square), and 
bioaugmented with KB-1© Plus (blue diamonds); a) bottle #1; b) bottle #2; 
and c) bottle #3........................................................................................... 88 
Figure 3.31 Results for Set V microcosms (BA/B-CS+B12) amended with cory syrup 
(indicated by arrows), B12 (red diamonds), NaHCO3 for pH adjustment 
(orange squares), and bioaugmented with DHM-1 (blue diamonds); a) 
bottle #1; b) bottle #2; and c) bottle #3 ...................................................... 89 
xiii 
List of Figures (Continued) Page 
Figure 3.32 Results for Set V microcosms (BA/B-SRS+B12) amended with vegetable oil 
(indicated by arrows), B12 (red diamonds), NaHCO3 for pH adjustment 
(orange squares), and bioaugmented with DHM-1 (blue diamonds); a) 
bottle #1; b) bottle #2; and c) bottle #3 ...................................................... 89 
Figure 3.33  Sulfate and volatile fatty acids (VFAs) analysis for Set V microcosms; a) 
sulfate concentrations for three different incubation days in representative 
bottles; b) VFAs and sulfate reudction (presented in mg COD/L) following 
476 days of incubation in representative bottles; halogenated methanes 
transformation controbited less than 4 % to COD utilization .................... 91 
Figure 3.34 Results for abiotic unamended microcosms (A-UN); a) bottle #1; b) bottle #2; 
and c) bottle #3........................................................................................... 92 
Figure 3.35 Results for abiotic microcosms (NaD) amended with sodium dithionite 
(indicated by arrows); a) bottle #1; b) bottle #2; and c) bottle #3. ............ 93 
Figure 3.36 Results for abiotic microcosms (Ti+Glu+B12) amended with stitanium 
chloride, corn syrup, and B12 (indicated by arrows); a) bottle #1; b) bottle 
#2; and c) bottle #3. ................................................................................... 94 
Figure 3.37 Results for abiotic/biotic microcosms (ZVI) amended with zero valent iron 
(indicated by arrows) and bioaugmented with KB-1© Plus (blue diamond); 
a) bottle #1; b) bottle #2; and c) bottle #3. ................................................ 95 
Figure 3.38 Results for abiotic microcosms (CaSX) amended with calcium polysulfide 
(indicated by arrows); a) bottle #1; b) bottle #2; and c) bottle #3. ............ 96 
Figure 3.39 Representative results for CF and 14C-CF in a control bottle with MSM but 
no enrichment culture. ............................................................................... 97 
Figure 3.40 Representative results for biodegradation of CF and 14C-CF by the KB-1© 
Plus culture. The bottles were sacrificed to evaluate the distribution of 14C 
after the CF was consumed but DCM was still present. ............................ 97 
Figure 3.41 Representative results for biodegradation of CF and 14C-CF by the KB-1© 
Plus culture. The bottles were sacrificed to evaluate the distribution of 14C 
after the CF and DCM were biodegraded below detection........................ 98 
Figure 3.42 Representative results for biodegradation of CF and 14C-CF by the KB-1© 
Plus culture in the presence of BES. The bottles were sacrificed to evaluate 
the distribution of 14C after the CF and DCM were biodegraded below 
detection. .................................................................................................... 98 
xiv 
Page List of Figures (Continued)
Figure 3.43 Distribution of 14C from treatments with 14C-CF added. Bars represent 
averages for 3 medium control bottles, 6 intemediate and no BES bottles, 9 
final and no BES bottles, and 6 final with BES bottles. Error bars are 
standard deviations. Percentages are in relation to the initial amount of 14C 
added. ......................................................................................................... 99 
Figure 3.43 DCM biodegradation in a single bottle with KB-1© Plus. BES was added on 
day 8 (indicated by blue diamond) along with another dose of DCM ....... 99 
Figure 3.44 Proposed pathway for the metabolism of DCM by Dehalobacter sp. in KB-1© 
Plus Culture .............................................................................................. 100 
xv 
ABBREVIATIONS 
AC Autoclaved Control(s) 









EVO Emulsified Vegetable Oil 
GC Gas Chromatograph 
HCFC-21 Dichlorofluoromethane 
HPLC High Performance Liquid Chromatograph 
LSC Liquid Scintillation Cocktail 
MSM Mineral Salt Medium 
NSR Nonstrippable Residue 
PRB Permeable Reactive Barrier 
SRS Slow Release Substrate 
VFA Volatile Fatty Acid 
ZVI Zero Valent Iron 
xvi 
CHAPTER ONE 
1.0 INTRODUCTION AND OBJECTIVES 
Halogenated methanes are among the most frequently encountered contaminants 
at hazardous waste sites. One such site in California is contaminated with chloroform 
(CF), carbon tetrachloride (CT), and trichlorofluoromethane (CFC-11). 1,1-
Dichloroethene (DCE) is also present, most likely as a consequence of prior use of 1,1,1-
trichloroethane, which was commonly used to stabilize halogenated solvents. 1,1,1-
Trichloroethane undergoes abiotic dehydrohalogenation to form 1,1-DCE, which often 
persists.  CF, CT and CFC-11 are the main focus of this research; they are present at the 
California site at concentrations in the mg per liter range and a plume of contaminated 
groundwater emanating from a source zone is approaching a property boundary, 
necessitating remediation. Anaerobic bioremediation is one of the technologies under 
consideration for addressing the source zone and the less concentrated downgradient 
plume. A microcosm study was performed to evaluate natural attenuation, biostimulation 
and bioaugmentation. A treatment approach using zero valent iron (ZVI) and other 
abiotic processes followed by bioremediation was evaluated by additional experiments.   
One of the cultures evaluated for bioaugmentation was KB-1© Plus (1), marketed 
by SiREM.  This mixed culture contains Dehalobacter spp. that chlororespire CF, 
yielding dichloromethane (DCM) as the terminal product.  Other types of Dehalobacter 
within KB-1 ©Plus are able to use DCM as a sole source of carbon and energy via 
organohalide fermentation.  The anticipated products from this fermentation include CO2, 
acetate, and hydrogen.  Nevertheless, a comprehensive analysis of the product 
1 
distribution has not previously been reported.  Consequently, another focus of this 
research was to determine the ultimate product distribution using 14C-CF. 
Another bioaugmentation culture evaluated as part of this research was DHM-1 
(2). This enrichment culture cometabolically biodegrades CT, CFC-11, and CF.  One of 
its most notable features is that biotransformation of these compounds results in only 
minor accumulation of halogenated daughter products. 
In order to better understand the basis for the objectives and experimental design 
of this research, prior studies on anaerobic cometabolic biodegradation of CF is 
summarized below.  This is followed by a summary of prior work on metabolic anaerobic 
biodegradation of CF and DCM and abiotic processes that have been used to treat 
halogenated methanes. 
1.1 Anaerobic Cometabolic Biodegradation of CF 
 CF biodegradation under anaerobic conditions may occur metabolically or 
cometabolically.  A summary of the main pathways involved is shown in Figure 1.1.   
 Reductive dechlorination of CF to DCM has been recognized for many years (3, 
4).  A wide variety of microbes have been shown to mediate this reaction cometabolically 
(5), i.e., they gain no growth-related benefit from the transformation.  Addition of 
electron donors stimulates the reduction process.  However, DCM tends to accumulate; 
further reductive dechlorination to chloromethane (CM) and methane is very slow and 
represents a minor part of the transformation process. Thus, reductive dechlorination of 
CF does not follow the same steps commonly observed with chlorinated ethenes, i.e., 
complete sequential biotic dechlorination to a nonhazardous endpoint (ethene).  CM and 
2 
methane have been detected as daughter products from CF, but the rate of formation is 
too slow for this to be a pathway of any practical relevance. 
 Accumulation of DCM is not inherently problematic, since fermentation of DCM 
to nonhazardous products is well established (see below).  However, at higher 
concentrations of CF (e.g., above 10 mg/L), biostimulation tends to proceed slowly, since 
CF strongly inhibits the metabolism of most anaerobic bacteria.  This includes the 
bacteria that ferment DCM as well as Dehalococcoides (6). One approach to mitigating 
the toxicity of CF is through addition of vitamin B12.  At a molar dose of approximately 
3% (i.e., mol B12 per mol CF), B12 significantly increases the rate of transformation and 
shifts the pathway away from reductive dechlorination towards hydrolytic dechlorination 
to carbon monoxide (Figure 1.1). In groundwater systems, CO is considered 
nonhazardous in the same manner ethene is from chlorinated ethenes.  Furthermore, CO 
is relatively short-lived, since many anaerobes use it as a carbon and energy source to 
produce organic acids (Figure 1.1).   
 Using samples of soil and groundwater from a former industrial site, Shan et al. 
(7) demonstrated complete biodegradation of 500 mg/L of CF, 8.8 mg/L of CT, and 26 
mg/L of CFC-11 via biostimulation with corn syrup and B12.  The basis for using corn 
syrup (as opposed to other electron donors) and B12 was observation of high rates of CT 
transformation by pure cultures of Acetobacterium woodii grown with fructose (8).  In 
microcosms prepared with soil and groundwater from the industrial site, Shan et al. (7) 
accelerated halomethane degradation by addition of a fermentative enrichment culture 
that grows on corn syrup.  Following further enrichment of the culture, it was designated 
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DHM-1 (9).  DHM-1 is able to grow on corn syrup while transforming 500 mg/L CF, as 
long as B12 and a low level of sulfide are available.  The mechanism of tolerance to such 
high levels of CF is associated with modifications in the cell membrane structure of the 
two types of microbes isolated from the enrichment culture that are responsible for CF 
biodegradation (9).  The principle products from [14C]CF transformation by DHM-1 were 
CO (67%), CO2 (2.7%), and soluble compounds (15%).  All of the other potential 
products, including DCM, CM, and methane, were negligible. Fractionation of the 
soluble compounds by high-performance liquid chromatography (HPLC) yielded mainly 
formate (36%) and propionate (13%). 
 A disadvantage to using B12 is its high cost.  Although on a molar basis the 
required dose is moderate, it is still considerably higher than what is typically needed to 
ensure robust growth of Dehalococcoides (10).  Subsequent studies have demonstrated 
that high rates of CF biodegradation are still possible at lower B12 doses, while still 
maintaining the advantage of minimizing accumulation of DCM (2).  For example, at a 
B12 dose of 0.4% (molar basis), the maximum rate of transforming 500 mg/L of CF 
decreased by only one half compared to a 3% dose.   
1.2 Anaerobic Metabolic Biodegradation of CF and DCM 
 Reductive dechlorination of CF to DCM via halorespiration has recently been 
described with Dehalobacter spp. (1, 10–12).  In this case, the bacteria use CF as a 
terminal electron acceptor, in the same way that Dehalococcoides use chlorinated 
ethenes.  Also like Dehalococcoides, hydrogen serves as the electron donor during 
organohalide respiration of CF.  A significant level of δ13C enrichment occurred during 
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CF reduction to DCM by the enrichment culture DHB-CF/MEL (13), suggesting that 
carbon specific isotope analysis will be a helpful tool for documenting in situ activity.  
The complete genome sequence for Dehalobacter UNSWDHB was recently reported, 
which will provide insights into how halorespiration occurs in these types of bacteria 
(12).  Information about the specific dehalogenase enzymes involved in use of CF as a 
terminal electron acceptor are starting to emerge (14).  
   The highest concentration of CF reportedly tested with organohalide-respiring 
Dehalobacter is 50-60 mg/L (11).  While Dehalobacter spp. may be capable of tolerating 
higher concentrations, the CF levels in the source areas at the former industrial site that is 
the subject of this research may present an impediment to use of this approach.  Based on 
concerns with inhibition of Dehalobacter spp., another bioaugmentation culture (DHM-
1) was also evaluated.  DHM-1 can biodegrade up to 2,000 mg/L of CF (~one quarter the 
water saturation concentration), as well as CT and CFC-11, without significant 
accumulation of halogenated products.   
 Unlike CF, DCM undergoes anaerobic biodegradation via fermentation as a sole 
carbon and energy source, i.e., it serves as an electron donor rather than an electron 
acceptor; the process has been referred to as halofermentation (11).  Acetate and possibly 
formate are the main products, along with biomass and chloride.  Freedman and Gossett 
(15) developed an anaerobic enrichment culture that consumed DCM as the sole carbon 
and energy source.  The culture produced stoichiometric amounts of methane (i.e., 0.5 
mol CH4/mol DCM) at low concentrations of DCM, while acetate and hydrogen 
accumulated at DCM concentrations that inhibited methanogenesis. Mägli et al. (16) 
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subsequently isolated a novel anaerobic bacterium, Dehalobacterium formicoaceticum 
strain DMC, that uses DCM as its sole source of organic carbon and energy. Strain DMC 
was isolated from a two-component culture, with the other member being a Desulfovibrio 
sp. (17).  The Desulfovibrio sp. provided strain DMC with growth factors, which made 
isolation of strain DMC that much more challenging.  Phylogenetic analysis of the 16S 
rDNA from Dehalobacterium formicoaceticum strain DMC revealed that it grouped 
closely to Clostridium bacillus and showed 89% sequence similarity with 
Desulfotomaculum orientis and Desulfitobacterium dehalogenans (16).  Mägli et al. (18) 
proposed a pathway for DCM biodegradation by strain DMC that involves components of 
the acetyl CoA pathway used by homoacetogens.  The predicted stoichiometry is 0.67 
moles of formate, 0.33 moles acetate, and 0.33 moles CO2 per mole of DCM.     
 More recently, Dehalobacter spp. have been identified that also grow 
anaerobically with DCM as the sole source of carbon and energy.  Justicia-Leon et al. 
(19) enriched for a Dehalobacter sp. with samples from an uncontaminated site, but 
managed to grow the culture with DCM as the sole substrate and acetate as the main 
product.  Lee et al. (11) demonstrated that  Dehalobacter spp. were responsible for DCM 
biodegradation in a microcosm evaluation of a contaminated site in Australia.  The KB-
1© Plus culture marketed by SiREM also contains DCM fermenting Dehalobacter sp.  
Studies with these cultures indicate that DCM is consumed without accumulation of 
volatile organic products.  However, the ultimate fate of DCM is not well understood.  
Given the importance of documenting that biodegradation yields non-hazardous products, 
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there is a need to evaluate the intermediate and ultimate products from fermentation of 
DCM by Dehalobacter spp. 
 By combining the strains of Dehalobacter that reductively dechlorinate CF to 
DCM with those that ferment DCM to non-hazardous products, the potential exists to 
achieve complete metabolically-driven anaerobic biodegradation of CF.  Lee et al. (11) 
reported this outcome for a site in Australia. Emulsified vegetable oil (EVO) was used as 
the electron donor to support reductive dechlorination of CF to DCM; fermentation of 
EVO provided the hydrogen needed for organohalide respiration.  A few limitations of 
their work are worth mentioning.  The two processes occur sequentially, i.e., reduction of 
CF to DCM occurred before fermentation of DCM began, since CF inhibited DCM 
fermentation.  Consequently, DCM accumulated until most all of the CF was consumed.  
Also, high concentrations of hydrogen inhibited DCM fermentation, suggesting that an 
excess of electron donor to stimulate CF reduction to DCM may prevent DCM 
fermentation until the concentration of hydrogen decreases.    
 Justicia-Leon et al. (20) also evaluated the potential for bioaugmentation to 
remove CF using two types of Dehalobacter spp.  In one of their experiments, both 
Dehalobacter enrichment cultures were added simultaneously to microcosms along with 
lactate (electron donor), fermentation of which provided hydrogen.  CF was reduced to 
DCM in 39 days.  Following a lag of 5 days, fermentation of DCM started.  It is 
noteworthy that DCM fermentation required addition of 10 mM bicarbonate to meet the 
CO2 requirement of Dehalobacter strain RM1.  Also, the presence of ~2.5 mg/L of 
carbon tetrachloride (CT) inhibited CF dechlorination to DCM.  This means that CT 
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removal is a prerequisite for the implementation of anaerobic biological remedies using 
culture Dhb-CF. 
 In spite of the challenges posed by using a mixture of specialized Dehalobacter 
spp. to achieve complete conversion of CF to non-hazardous products, the promise of a 
successful outcome is sufficient to warrant evaluation for bioremediation of the industrial 
site that is the subject of this research.  Bioaugmentation with DHM-1 or Dehalobacter 
spp. will require control of pH in the circumneutral region, since the activity of the 
microbes involved declines significantly at pH levels below 6.  Consequently, the 
experimental design for this research included treatments with pH control.  It is also 
noteworthy that groundwater at the former industrial site has moderately high levels of 
sulfate (~2000 mg/L).  The impact of sulfate as a competing electron acceptor and the 
tolerance of Dehalobacter spp. to sulfide is not well established.  The microcosm study 
by Shan et al. (7) with soil and groundwater from a former industrial site indicate that 
sulfate should not interfere with the activity of DHM-1; indeed, DHM-1 requires sulfide 
to be effective in cometabolizing CF.   
1.3 Anaerobic Abiotic/Biotic Dehalogenation 
Since high concentrations of halomethanes (e.g., >10 mg/L) may pose challenges 
for a bioremediation-only strategy, abiotic processes have also been investigated, often in 
combination with follow-on bioremediation.  For example, the combination of ZVI 
treatment of CT followed by bioaugmentation to remove CF has been demonstrated (20). 
CT was reduced in situ primarily to CF by a ZVI permeable reactive barrier ( ZVI PRB). 
Samples of treated water containing CF were collected, buffered with potassium 
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phosphate (pH~7.2), and used to prepare microcosms.  The microcosms were 
bioaugmented with the CF-to-DCM-dechlorinating culture Dhb-CF, and subsequently 
with the DCM-degrading consortium RM (which required addition of bicarbonate). CF 
was completely detoxified via metabolic pathways, as described above. A similar 
approach was evaluated as part of this research for the contaminated site in California.   
Similar to ZVI, sodium dithionite (Na2S2O4) has been evaluated as a chemical 
reductant for transformation of CT to CF in anoxic groundwater obtained from the 
Department of Energy’s Hanford facility in the state of Washington (21). Approximately 
10% of the CT was transformed to CF. Sulfide or structural Fe(II) was postulated as the 
reactive reagent that transformed CT. Sodium dithionite was evaluated as part of this 
study. 
Titanium (III) citrate is another chemical agent that reportedly transforms CT to 
CF. The reaction was catalyzed by B12, with higher transformation rates at pH 10.3 than 
at 7.3 (22). In a continuous flow column study, addition of titanium(III) citrate, glucose, 
and B12 stimulated in-situ remediation of CT, CF, tetrachloroethene, trichloroethene, cis-
DCE, and trans-DCE (23). Titanium (III) citrate, B12, and corn syrup were evaluated as 
an abiotic treatment strategy as part of this study.  
Calcium polysulfide (CaSX) has been used successfully for in situ remediation to 
reduce hexavalent to trivalent chromium (24). Literature on the use of CaSx for 
halogenated methanes was not found.  Nevertheless, since it is a strong reducing agent, 
its effectiveness for removal of halogenated methanes was evaluated as part of this study. 
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1.4 Objectives 
 The overall objective of this research was to determine if anaerobic 
bioremediation and/or abiotic degradation can be used to remediate the source zone and 
leading edge of a contaminant plume (containing mainly CF, CT, and CFC-11) at an 
industrial site in California.  The specific objectives of this thesis were: 
 1)  To determine the effectiveness of biostimulation at removing halogenated 
methanes in the downgradient and upgradient locations.  Three types of electron donors 
were tested; two relatively fast acting (corn syrup and lactate) and one longer lasting 
(Slow Release Substrate (SRSTM), from Terra Systems).  The effect of B12 was also 
evaluated with corn syrup, since the benefits of adding B12 are better documented with 
corn syrup versus lactate.  Addition of B12 was also be evaluated with SRS™, to 
determine if the same advantages observed with corn syrup can be achieved with a 
longer-lasting electron donor.  For each location, the concentration of major competing 
electron acceptors (e.g., nitrate and sulfate) was monitored.   
 2)  To determine the effectiveness of bioaugmentation for improving the 
biodegradation rate for halogenated methanes in the downgradient and upgradient 
locations.  KB-1© Plus (containing the required mixture of Dehalobacter spp.) was 
evaluated for the downgradient and upgradient locations, while DHM-1 was tested with 
only the higher concentration upgradient location.  KB-1© Plus is advantageous from the 
perspective that it does not require B12 and the downgradient location has low 
concentrations of potentially inhibitory compounds (e.g., CT).  On the other hand, the 
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upgradient location was more likely to have inhibitory compounds and a prior study 
indicated DHM-1 can be effective in that type of environment (7).     
 3)  To determine the effectiveness of pH adjustment for accomplishing 
biostimulation and bioaugmentation at the downgradient location.  Since groundwater at 
the downgradient location has a pH greater than 6, bioremediation may be feasible 
without pH adjustment, although the buffering capacity in this area is not well 
established.  All treatments for the upgradient location were pH-adjusted, since the 
current pH is already below 6 and dechlorination of higher concentrations of CF will 
drive the pH even lower.  Sodium bicarbonate was used for pH adjustment.   
 4)  To determine the effectiveness of abiotic and combined abiotic/biotic 
processes for treating the upgradient location.  These processes included ZVI followed by 
bioaugmentation with KB-1© Plus, sodium dithionite, calcium polysulfide, and a 
combination of titanium(III) citrate + B12 + corn syrup.   
 5)  To perform a mass balance for CF during biodegradation by the KB-1© Plus 
culture, using 14C-CF.  Although previous studies have suggested that the end products 
are non-hazardous, a complete mass balance to confirm this has not yet been performed.   
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CHAPTER TWO 
2.0 MATERIALS AND METHODS  
2.1 Chemicals and Medium 
 CF (99.7%) was obtained from Shelton Scientific. Spectrophotometric grade CT 
(99+ %) was obtained from Acros Organics. ClFCH2 (99% min) was obtained from 
SynQuest Labs., Inc. Methane gas, high purity H2 gas, high purity N2 gas, and dry 
breathing air were obtained from Airgas. CM (99.9%) was obtained from Praxair. CFC-
11 (99+%) and sodium 2-bromoethanesulfonate (98%) were obtained from Sigma-
Aldrich. DCM (99.99%) was obtained from Burdick & Jackson. Methanol (99.9%) was 
obtained from EMD. Sodium lactate syrup (containing 58.8-61.2% sodium lactate; 
specific gravity = 1.31) was obtained from Spectrum Chemical MFG Corporation. 
Sodium bicarbonate powder (‘Baker analyzed’ HPLC reagent), sodium formate (crystal, 
99.3%), sodium dithionite (89%), and resazurin sodium derivative were obtained from 
J.T. Baker. Stabilized titanium (III) chloride solution (20%) was obtained from Fisher 
Chemical. [14C]CF was obtained from American Radiolabeled Chemicals (0.5 
mCi/mmol). Liquid scintillation cocktail (LSC) “Scintisafe Plus” (50%) was obtained 
from Fisher Scientific. Calcium polysulfide (29% w/w) was obtained from Craus 
Chemicals. ZVI powder was obtained from Hepure Technologies Inc. All other 
chemicals used were reagent grade, unless indicated otherwise. 
12 
2.2 Sources for the Bioaugmentation Cultures  
 The DHM-1 enrichment culture developed by Shan et al. (9) is maintained in the 
Freedman laboratory. Activated culture was prepared for bioaugmentation by transferring 
5 mL of a refrigerated stock culture to 95 mL of freshly prepared anaerobic mineral 
medium (Appendix A) in a 160 mL serum bottle.  CF (500 mg/L) was added along with 
B12 (1.84 mL of 1% w/v B12 solution, resulting in 3% of the CF on a molar basis) and 
corn syrup (0.45 mL of 200 g/L corn syrup).  Following biodegradation of the CF to less 
than 0.1 mg/L, aliquots were used for bioaugmentation of selected microcosms. 
 KB-1© Plus culture was obtained from SiREM, shipped on ice to Clemson 
University via an overnight carrier. Upon receipt, the culture was placed in an anaerobic 
chamber and allowed to warm to room temperature overnight.  Aliquots were then used 
to bioaugment selected microcosms, or to prepare experiments for evaluating the fate of 
14C-CF. 
2.3 Sample Locations and Conditions 
 For the downgradient location, soil was collected during the installation of new 
monitoring wells (locations MW-64 and MW-65).  Soil samples (AS-MW-65_S112 and 
AS-MW-65_S116) were composited for use in the microcosms.  At least 5 L of 
groundwater was collected from a newly developed well (AS-MW-65_115).  
Representative concentrations at this location are 1.9 mg/L CF, 1.3 mg/L CFC-11, 0.038 
mg/L CT, 0.44 mg/L DCM, 0.082 mg/L chlorodifluoromethane, 0.071 mg/L 
dichlorodifluoromethane, 0.077 mg/L o-xylene, 0.12 mg/L dichlorodifluoromethane, 
0.038 mg/L methane, and 2600 mg/L sulfate. 
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 For the upgradient location, soil was not available.  Therefore, the same soil 
described above was used.  Representative groundwater (collected from well AS-MW-
63_110) concentrations for the upgradient location were 30 mg/L CF, 0.71 mg/L CFC-
11, 0. 37 mg/L CT, 0.27 mg/L DCM, 0.12 mg/L chlorodifluoromethane, 0.32 mg/L 
dichlorodifluoromethane, 0.28 mg/L 1,1-dichloro-1-fluoroethane, and 1800 mg/L sulfate.   
 Soil and groundwater samples were delivered to Clemson University, on ice, on 
February 22, 2014. 
2.4 Experimental Design for Microcosms 
 The overall plan for the biotic experiments (sections 2.4.1 and 2.4.2) is outlined in 
Table 2.1. A total of 30 treatments were prepared, each in triplicate, for a total of 90 
microcosms. The microcosms were divided into two groups, which differ by the location 
of the groundwater and therefore the concentrations of contaminants. The first group 
(Sets I, II and III) evaluated low-to-medium concentrations found in the vicinity of the 
downgradient part of the plume (AS-MW-64&65), with groundwater containing 
approximately 2 mg/L of CF. The second group (Sets IV and V) evaluated the high 
concentrations found just downgradient of the source area, in the vicinity of AS-MW-16, 
with groundwater containing approximately 30 mg/L of CF. Justification of the 
treatments within in each group is provided below. 
2.4.1 Low-to-Medium Concentration Biotic-Only Microcosms 
 Three sets of treatments were prepared, as follows. 
 Set I, Controls:  Water controls consisted of DDI water (50 mL) and enough glass 
beads to displace the same volume of water as soil added to the other treatments.  The 
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volume displaced by 20 g of soil was approximately 10 mL.  CT, CF, DCM, and CFC-11 
were added in order to reach the target concentrations using water-saturated solutions.  
Killed controls consisted of soil and groundwater that was autoclaved for 1 h on three 
consecutive days.  Since autoclaving decreased the concentration of contaminants, the 
target concentrations were established by adding water-saturated solutions when 
autoclaving was complete.   
Set II, without pH Adjustment:  Since field measurements of groundwater pH in 
the location of concern are greater than 6, bioremediation may be feasible without pH 
adjustment.  Note, however, that the groundwater pH as received at Clemson University 
was 5.9.  Treatment #3 (Table 2.1) was prepared without substrate, to serve as a live 
control.  Biostimulation treatments included amendment with lactate, corn syrup, corn 
syrup + B12, SRSTM, and SRSTM + B12 (Table 2.1, #4 through #8).  The lactate-only 
treatment served as a control for one of the bioaugmentation treatments (Table 2.1, #9), 
using KB-1© Plus (identified as “Bioaugmentation (A)” in Table 2.1).  Since KB-1© Plus 
also functions with EVO, a bioaugmentation treatment with KB-1© Plus and SRSTM was 
also included in Set II (Table 2.1, #10).  SRSTM contains mostly food-grade soybean oil 
with some sodium lactate, emulsifiers, and a proprietary nutrient package 
containing nitrogen, phosphorus, and B12 (Terra Systems, http://www
.terrasystems.net/Products/products_SRS.htm).   
The current pH conditions may be conducive to bioaugmentation.  For Set II, KB-
1© Plus was used along with lactate or SRSTM.  KB-1© Plus is a candidate for this 
location since the CF level is not inhibitory and the concentration of co-contaminants, 
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including CT, are low enough that they too are not expected to be inhibitory.  As the 
results will show, KB-1© Plus was effective in removing CF and DCM, although CFC-11 
persisted.  Treatment #9 was subsequently amended with DHM-1, to evaluate its 
potential to remove the CFC-11.     
Set III, with pH Adjustment:  Bioremediation was also evaluated with pH 
adjustment, using the same eight treatments described above for Set II.  The groundwater 
pH as received was 5.9. Sodium bicarbonate was used to raise the initial pH to 6.6 and 
maintain it in the range of 6.5-7.5 (described below).  As the results will show, KB-1© 
Plus was effective in removing CF and DCM, although CFC-11 persisted.  Treatment #17 
(Table 2.1) was subsequently amended with DHM-1, to evaluate its potential to remove 
the CFC-11. 
2.4.2 High Concentration Biotic-Only Microcosms 
Two sets of treatments were prepared, as follows. 
Set IV, Controls:  The same type of controls (water-only and autoclaved) were 
constructed as described above for the low-to-medium concentration microcosms (Table 
2.1, treatments #19 and #20).   
Set V, with pH Adjustment:  Since field measurements of groundwater pH in the 
location of concern are less than 5, it is unlikely that bioremediation will be feasible 
without pH adjustment, so this option was not evaluated.  The pH of groundwater from 
AS-MW-63 as received at Clemson University was 6.0. pH adjustment to 6.9 and 
subsequent maintenance (6.5-7.5) was accomplished with sodium bicarbonate.  The first 
eight treatments described above for the low-to-medium concentration (i.e., Set III) were 
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also prepared for the high concentration conditions (Table 2.1, treatments #21 through 
#28).  Of concern was the possibility that CF levels would be inhibitory to KB-1© Plus.  
For this reason, two additional treatments were evaluated (Table 2.1, #29 and #30), using 
the DHM-1 culture described by Shan et al. (9); DHM-1 is designated by 
“Bioaugmentation (B)” in Table 2.1.  DHM-1 biodegrades CF concentrations up to 2,000 
mg/L, when provided with corn syrup and a catalytic level of B12.  A treatment with 
SRSTM as the electron donor in place of corn syrup was also evaluated, given the longer 
lasting property of SRSTM. 
2.4.3 High Concentration Abiotic/Biotic Microcosms 
Five treatments were prepared with source zone groundwater, as follows. 
1) Unamended live controls, which had the same composition as what was
prepared in Set V (Table 2.1, treatment #21); 
2) Addition of ZVI, followed by bioaugmentation with KB-1© Plus;
3) Addition of sodium dithionite;
4) Addition of calcium polysulfide; and
5) Addition of a combination of titanium citrate + B12 + corn syrup.
The pH of the groundwater was not adjusted. The amount of each compound added is 
reported in Appendix B.  
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2.5 Products from Biodegradation of CF by KB-1© Plus 
 The fate of CF during biodegradation by the KB-1© Plus culture was evaluated 
on three occasions (Sets I, II and III), outlined below.  The procedure used to determine 
the distribution of 14C is presented in section 2.7.5.  
2.5.1 Set I 
The KB-1© Plus culture was received in six serum bottles (160 mL).  Upon 
receipt from SiREM, the bottles were placed in an anaerobic chamber and allowed to 
warm to room temperature overnight.  The volumes were adjusted to 100 mL inside an 
anaerobic chamber and then removed.  The headspace of each bottle was then sparged 
with a gas mixture (70% N2/30% CO2) to remove hydrogen that was present in the 
atmosphere of the anaerobic chamber.  Unlabeled CF saturated water (0.25 mL) and a 
stock solution of sodium lactate (25 µL; 650 g/L of 60% sodium lactate syrup) were 
added. After this initial addition of CF was completely biodegraded, triplicate medium 
controls were prepared by adding 100 mL of a modified mineral salt medium (MSM) 
(Appendix A) to 160 mL serum bottles, inside the anaerobic chamber. The same dose of 
CF saturated water was added to all nine bottles and lactate was added to the six bottles 
containing the KB-1© Plus culture. 
Next, 14C-CF was added to all nine bottles.  This was accomplished using an 
aqueous stock solution containing 14C-CF.  The procedure used to purify the 14C-CF prior 
to injecting it into the serum bottles is described in section 2.7.5.  After adding the 14C-
CF, the nine serum bottles were mixed on a shaker table (100 rpm) for 1 h, to allow the 
CF to equilibrate between the headspace and liquid phases. Headspace and liquid samples 
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were used to establish the initial amount of 14C-CF present.  The bottles were then 
incubated quiescently.  Headspace samples were removed periodically to determine the 
total levels of CF, DCM, CM and methane present.  After CF was removed but DCM was 
still present, three of the bottles were sacrificed to determine the distribution of 14C (see 
below).  The other three bottles with culture were incubated until both CF and DCM were 
no longer detectable, at which point these and the medium controls were sacrificed to 
determine the distribution of 14C.       
2.5.2 Set II 
On a second occasion, additional KB-1© Plus culture was received in nine serum 
bottles.  After adjusting the volumes to 100 mL, 1.05 g of BES (Appendix C) was added 
to three of the bottles for the purpose of inhibiting methanogenesis.  Medium controls 
were not prepared with this set.  Also, 14C-CF was added without first “priming” the 
culture with unlabeled CF alone.  As with Set I, triplicate bottles without BES added 
were sacrificed once the CF was consumed but some DCM remained.  The other three 
bottles without BES were sacrificed once CF and DCM were below detection.  Once CF 
and DCM were consumed in the bottles with BES added, these were also sacrificed to 
determine the distribution of 14C.    
2.5.3 Set III 
On a third occasion, KB-1© Plus culture was received in a single 1 L media bottle. 
After warming up the bottle, unlabeled CF (4.4 mL of CF saturated water) and lactate 
(0.45 mL of a 650 g/L sodium lactate solution, 60% syrup) were added “prime” the 
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culture before adding 14C-CF, as was done with Set I.  Once the CF was consumed and 
no DCM remained, the contents of the 1 L bottle was dispensed to nine serum bottles and 
incubated as described for Set II.  
2.6 Microcosm Preparation 
The microcosms consisted of 160 mL serum bottles containing 20 ± 0.2 g of 
sediment and 50 mL of groundwater. Resazurin was added to the groundwater (1 mg/L) 
to serve as a redox indicator.  Controls consisted of microcosms that were autoclaved 
(three consecutive days) and then spiked with the halogenated methanes, and water 
controls containing only deionized water and the halogenated methanes.  Spiking the 
autoclave controls (AC) with halogenated methanes was necessary due to abiotic losses 
during autoclaving.    
All of the bottles were prepared in an anaerobic chamber, to exclude the 
introduction of oxygen and hasten the development of anaerobic conditions.  Hydrogen 
was introduced from the anaerobic chamber’s atmosphere, which consisted of ~2% 
hydrogen, the balance being nitrogen.  This amount of hydrogen was sufficient to serve 
as a significant electron donor for reductive dechlorination of CF to DCM. 
Consequently, it was necessary to sparge the headspace of each microcosm with pure N2 
after removing the serum bottles from the anaerobic chamber.  After sealing the bottles 
and allowing the headspace to equilibrate with the groundwater, the remaining 
concentration of volatile compounds was measured (see below). More CF, DCM, CFC-
11, and CT were added using water-saturated solutions to reach the target levels.    
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When not being sampled, the bottles were stored in the anaerobic chamber at 
room temperature (22-24°C) to minimize any opportunity for introducing oxygen via 
diffusion through the septa.  The samples were handled aseptically, to ensure that any 
microbial activity observed in the microcosms was a result of organisms derived from the 
samples and not contaminants introduced during microcosm preparation.     
2.7 Analytical Methods 
2.7.1 Volatile Organic Compound (VOC) Analysis 
Halogenated (CT, CF, DCM, CM, CFC-11, HCFC-21) and nonhalogenated 
volatile compounds (methane) were monitored by gas chromatographic analysis of 
headspace samples (0.5 mL), as previously described (25).  A Hewlett Packard 5890 
Series II gas chromatograph (GC) was used, equipped with a flame ionization detector 
and a 2.44-m × 3.175-mm column packed with 1% SP-1000 on 60/80 Carbopack B 
(Supelco).  The gas chromatograph response to a headspace sample was calibrated to give 
the total mass of compound in that bottle (26). Assuming the headspace and aqueous 
phases are in equilibrium, the total mass present was converted to an aqueous phase 
concentration (Eq 1): 
(1) 
where Cl = concentration in the aqueous phase (µM); M = total mass present 
(µmol/bottle); Vl = volume of the liquid in the bottle (L); Vg = volume of the headspace in 





concentration)) at 23°C.  With the headspace method, detection limits were lower than 
the maximum contaminant level for each of the regulated halogenated compounds.   
Neat compounds were used to prepare standards for determination of response 
factors, with the exception of dichlorofluoromethane (HCFC-21).  HCFC-21 was not 
available, so a response factor determined by Shan et al. (7) was used instead.   
2.7.2 pH Measurement and Adjustment 
pH was measured in 0.2 mL of settled liquid.  Samples removed from the 
microcosms were placed in a conical vial (1.4 mL).  A SympHony Ag/AgCl probe 
(VWR) was used with a SympHony SB70P meter (VWR).  Less than 1 min was required 
for the probe to reach a stable reading.  The probe was calibrated at pH 4 and 7 prior to 
each use.  The pH levels in Set III and Set V microcosms were measured on several 
occasions. Microcosms that had a pH value lower than 6.5 were adjusted to circumneutral 
by adding a stock solution of sodium bicarbonate (75 g/L). One or two doses were 
usually required to raise pH above 6.5; however under no circumstances was more than 
0.4 mL of the stock solution added in a single event, to avoid overdosing. As needed, the 
pH was measured again after incubating the bottles for 2 to 3 h and 0.2-0.4 mL of 
additional bicarbonate was added. 
2.7.3 Organic Acids 
After allowing solids in the microcosms to settle out, 20 µL was removed, diluted 
100-fold with DDI water, and filtered (0.20 µm PTFE syringe filter; the first 0.5 mL was
wasted in order to condition the filter).  Organic acids (including lactate, acetate, and 
propionate) were measured by HPLC using a 3000 Ultimate Dionex HPLC system and an 
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Aminex® HPX-87H ion exclusion column (300-mm × 7.8-mm; BioRad).  Eluent (5 mM 
H2SO4) was pumped (0.6 mL/min) through the column into a UV/Vis detector set at 210 
nm. The injection volume was 100 μL.  
2.7.4 Nitrate and Sulfate 
Samples for anion analysis were prepared as described above.  Nitrate and sulfate 
were measured on a Dionex AS50 ion chromatography system equipped a CD25 
Conductivity detector and a Dionex guard column (AG9-HC, 4 mm×50 mm) followed by 
an IonPac® AS9-HC anion-exchange column (4 mm×250 mm).  Eluent (9 mM Na2CO3) 
was delivered at 1.0 mL per min (25).  The injection volume was 25 µL.   
2.7.5 14C Methods 
To purify the stock and ensure that the only 14C entering the bottles was CF, the 
stock solution was purified using the same approach described by Darlington et al. (27).  
Briefly, the 14C-CF stock solution (100 μL) was injected onto a gas chromatograph and 
passed through the same packed column used to analyze the volatile organic compounds 
(see above).  The outlet of the column was connected to stainless steel tubing (1.59 mm) 
that exited the GC oven and terminated with a needle, which was inserted into the 
microcosm headspace during the interval when CF eluted (~6.5-7.0 min).  N2 was used as 
the carrier gas (28.5 mL/min at 150oC). At the time when CF eluted, the needle was 
injected into a serum bottle.  Preliminary experiments with water controls confirmed that 
the only volatile compound present following this procedure was CF. 
The total initial amount of 14C was quantified by counting samples of the 
headspace (0.5 mL) and liquid (1 mL) in 15 mL liquid scintillation cocktail. At the point 
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when a bottle reached incubation endpoint, the total remained amount of 14C within the 
bottle was again quantified by counting method mentioned before.  The distribution of 
14C remaining in a serum bottle at the time it was sacrificed is described by Darlington et 
al. (27), summarized below. 
Volatile 14C-labeled biodegradation products (primarily DCM and CH4) were 
analyzed with a GC-combustion technique (Appendix D). A 0.5-mL headspace sample 
from the microcosms (prior to adding NaOH) was injected onto the Carbopack B column 
and the separated compounds were routed to a catalytic combustion tube (containing 
CuO), where the compounds were oxidized at 800°C to CO2.  Each fraction was then 
trapped in 3 mL of 0.5 M NaOH and added to 15 mL LSC.  The efficiency of the 
combustion technique (Σ14C in the fractions divided by the 14C in a headspace sample) 
averaged 101±20% for the Carbopack column.  
14CO2 and 14C-labeled nonvolatile end products were measured after analysis of 
the 14C-labeled volatile compounds was completed. After raising the pH of the liquid to 
drive the CO2 in headspace into the liquid phase (by adding 0.9 mL of 10 M NaOH), 
samples of the liquid phase (10 mL) were transferred to a test tube that was connected to 
a second test tube containing 10 mL 0.5 M NaOH. High purity nitrogen gas was sparged 
into the first tube and over into the second. The pH in the first tube was then lowered by 
injecting 0.25 mL of 6 M HCl, to facilitate stripping of CO2, which was trapped in the 
second tube. 14C activity remaining in the first tube was referred to as nonstrippable 
residue (NSR).  The percent distribution of 14C, including losses, was calculated as 
described elsewhere (14). 
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The distribution of 14C in NSR was evaluated by injecting filtered samples (100 
µL) onto a Dionex Ultimate 3000 HPLC using 5 mM H2SO4 as the eluent and an 
Aminex® HPX-87H column (300 mm × 7.8 mm) for separation of organic acids.  Eluent 
samples were collected in LSC according to the elution times for formate and acetate 
(based on the retention times of authentic material). As the results will show, the activity 
recovered as NSR was sufficiently low such that fractionation by HPLC was unlikely to 
yield adequate activity.  To account for this, samples from bottles with more than 5% 
NSR were injected onto the HPLC three separate times, and the same fractions were 
trapped each time.  The intent was to allow for sufficient accumulation of 14C activity in 
order to associate a particular fraction with a specific organic acid.   
A PerkinElmer Tri-Carb® 2910 TR liquid scintillation counter was used to 
quantify 14C activity. Corrections for counting efficiency were made according to a 
quench curve (sample spectral Quench Parameter-Ethernal (i.e., SQP(E)) versus 
efficiency) after incubating them overnight in the dark. 
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CHAPTER THREE 
3.0 RESULTS  
3.1 Low Concentration Biotic Microcosms 
3.1.1 Controls (Set I) 
The water control results (Figure 3.1) demonstrate there was no appreciable 
diffusive loss of CT, CFC-11, CF or DCM following 461 days of incubation.  In the 
autoclaved controls (Figure 3.2), CT was degraded within the first 26 days of incubation 
and CFC-11 decreased by approximately 9.7% during 456 days of incubation, while there 
was no appreciable change in the CF or DCM concentration.  Abiotic degradation of CT 
has been reported previously, although as will be shown below, the rate in the autoclaved 
controls was actually higher than in the live treatments. The persistence of CFC-11, CF, 
and DCM in the autoclaved controls is consistent with other studies and indicates 
adsorption was not a significant factor in these microcosms.    
3.1.2 Live, No pH Adjustment (Set II) 
There was no significant decrease in CT, CFC-11, CF or DCM in the unamended 
microcosms during 482 days of incubation (Figure 3.3).  The unamended microcosms 
represent the closest simulation of in situ conditions.  The groundwater pH as received 
was 5.85.  The pH in bottle #1 was 4.64, 5.31, 5.40, and 5.49 on days 104, 145, 337, and 
350 respectively.  A pH level below 6 is not conducive to reductive dechlorination or 
organohalide fermentation of DCM.    
Within 139 days of incubation, CT was consumed below detection in the three 
microcosms amended with lactate (Figure 3.4) and with corn syrup (Figure 3.5). 
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However, there was no significant decrease in CFC-11, CF or DCM.  The pH in the 
lactate amended microcosms increased to approximately 6.7, since sodium lactate 
functions as a weak base.  The pH in the corn syrup amended microcosms was similar to 
the unamended treatment (~5.4).  CT was consumed within 120 days in the treatment 
with corn syrup and B12 (Figure 3.6).  In one of these microcosms, there was a modest 
decrease in CFC-11 and a corresponding increase in CHCl2F.  However, B12 along with 
corn syrup did not appreciably improve biodegradation of CF and DCM in the Set II 
microcosms.  The pH in this treatment was measured on three occasions and ranged from 
5.4 to 5.8.   
The onset of CT degradation was slower in the SRS amended microcosms, 
requiring 250 days or longer for complete degradation in two of the bottles (Figure 3.7). 
There was no evidence of CFC-11, CF or DCM biodegradation in this treatment.  The pH 
in this treatment was more variable, ranging from 5.0 to 6.1.  Addition of B12 along with 
SRS improved the rate of CT biodegradation over SRS alone, with complete removal by 
day 171 (Figure 3.8). Nevertheless, there was no evidence of CFC-11, CF, or DCM 
biodegradation.  The pH ranged from 5.3 to 6.3.     
The treatment that was bioaugmented with KB-1© Plus and received lactate as the 
electron donor was the most effective (Figure 3.9).  CT was removed at a similar rate to 
the treatment with only lactate added.  In bottles #1 and #3, CF and DCM underwent 
simultaneous removal in approximately one month; during this interval, CFC-11 
decreased by approximately 0.7-0.9 µmol/bottle, with a corresponding increase in 
CHCl2F.  Thereafter, CFC-11 remained relatively constant through approximately day 
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425. In bottle #2, biodegradation of CF and DCM proceeded at a slower rate, and
degradation of CF slowed, reaching 0.125 µmol/bottle (0.24 mg/L) by day 472. It is 
notable that the extent of reductive dechlorination of CFC-11 was lower in this bottle 
compared to the others, with accumulation of CHCl2F reaching only 0.24 µmol/bottle.  
The pH in the bioaugmented treatment was similar to the pH in the treatment with only 
lactate added, ranging from 6.4 to 6.7.  A pH in this range is conducive to growth of KB-
1© Plus.   
In spite of the strong performance of KB-1© Plus with CF and DCM in treatment 
#9 (Figure 3.9), CFC-11 persisted until day 453, when reduction to CHCl2F accelerated.  
The reason for this is not clear, although it may have been a result of CF inhibition, such 
that when CF was sufficiently low, reduction of CFC-11 commenced.  KB-1© Plus is not 
known for its ability to degrade CFC-11.  In an attempt to remove the remaining CFC-11 
and CF in bottle #2, the microcosms were bioaugmented on day 457 with the DHM-1 
culture + corn syrup solution + B12.  Additional monitoring is needed to ascertain if 
addition of DHM-1 was effective.     
SRS was a moderately effective electron donor for the KB-1© Plus 
bioaugmentation culture with Set II (Figure 3.10).  CT was completely removed within 
200 days.  CF and DCM were biodegraded to varying extents, although none of the 
bottles reached the maximum contaminant level for drinking water (80 µg/L for CF, 5 
µg/L for DCM).  As with the other Set II treatments, CFC-11 persisted although a modest 
increase in CHCl2F occurred as CF and DCM decreased.  Addition of DHM-1 near the 
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end of the incubation period (day 457) was not effective in removing CFC-11 ; additional 
monitoring is need to assess this action.   
As with the other Set II SRS treatments, the pH was variable, ranging from 5.6 to 6.4.   
In addition to halomethanes, the Set II microcosms were evaluated for anions and 
organic acids.  Nitrate was below 0.2 mg/L in the groundwater and below detection in all 
of the microcosm samples.  The initial sulfate concentration in the low concentration 
groundwater was 3,110±60 mg/L.  This compares to 2,600 mg/L reported for field 
monitoring data.  Sulfate was measured on three occasions (Figure 3.11a).  Towards the 
end of the incubation period, 76-99% of the sulfate was consumed in the treatments with 
lactate and corn syrup added, compared to 34-43% in the treatments amended with SRS. 
This indicates that SRS was not as readily fermented and used as a substrate for sulfate 
reduction.  The total amounts of electron donor added were 2.2-2.5 fold higher than 
required for sulfate reduction and dehalogenation, assuming complete oxidation of the 
donor; assuming only a portion of the lactate, corn syrup and EVO was fermentable to 
hydrogen and acetate was not utilized for sulfate reduction or dehalogenation, the ratio of 
electron donor available to the demand was still sufficient to meet the demand (Table 
3.2).  It is important to note that the frequency of electron donor additions was increased 
significantly after day 321, when it was realized that considerable levels of sulfate still 
remained and that sulfate could have been inhibiting dehalogenation.    
Figure 3.11b provides a chemical oxygen demand (COD) balance for the Set II 
microcosms on day 476.  This encompasses the COD consumption associated with 
sulfate reduction as well as accumulation of acetate and propionate.  Other organic acids 
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(succinate, formate and lactate) were below detection.  Although the balances are 
incomplete, this figure communicates that most of the COD consumption was attributable 
to sulfate consumption and acetate formation.  Dehalogenation is not shown since it 
contributed less than 0.2% to the COD balance.   
Table 3.2 also summarizes the target and actual amounts of B12 and 
bioaugmentation culture added.  Repeat doses were made in an attempt to stimulate 
biodegradation activity.    
3.1.3 Live, pH Adjusted (Set III) 
Sodium bicarbonate was used to raise the initial pH of the groundwater (AS-MW-
65) from 5.9 to 6.6.  The pH in the unamended microcosms was checked several times
(days 103, 144, 222, 336, 349, 376, 400, 421, 436, and 469) and remained in the range of 
6.5 to 7.0.  Nevertheless, there was no significant biodegradation of CT, CFC-11, CF or 
DCM in the unamended microcosms (Figure 3.12).   
CT was consumed in all of the donor-amended treatments (Figures 3.13-3.19) at 
rates that were similar to or somewhat faster in comparison to the non-pH adjusted 
treatments of Set II.  The pH-adjusted, lactate-amended microcosms (Figure 3.13) were 
more active than the companion treatment in Set II (Figure 3.4).  DCM was biodegraded 
below detection in two of the three bottles, but stalled at 0.088 µmol/bottle (0.13 mg/L) 
in bottle #3.  CF was consumed below detection in bottle #3 and decreased to 0.5-0.7 
µmol (1.0-1.3 mg/L) in bottles #1 and #2, before activity stalled.  The higher level of CF 
removal in bottle #3 compared to that in bottle #1 and #2 corresponded to a much greater 
level of reductive dechlorination of CFC-11 to CHCl2F, which increased to 2.1 
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µmol/bottle; CHCl2F accumulated to only 0.46 and 0.53 µmol in bottles #1 and #2, 
respectively.  These results suggest the presence of indigenous Dehalobacter spp. capable 
of respiring CF and fermenting DCM.  The reason for the variability in CF and DCM 
biodegradability among the triplicates is not known.  The pH remained favorable 
throughout the 470 days of incubation, in the range of 6.7 to 7.0.   
In the treatment with corn syrup added, consumption of CT was followed by 
reductive dechlorination of CFC-11 to CHCl2F; however, activity levelled off after the 
initial onset. CFC-11 transformation resumed somewhat after day 334 when the 
frequency and amount of corn syrup was increased (Figure 3.14). Regardless, there was 
no evidence of CF or DCM biodegradation.  It was necessary to raise the pH several 
times using sodium bicarbonate, since it fell below 6.5 as a consequence of fermentation 
of the corn syrup to organic acids.  The treatment with corn syrup + B12 added behaved 
similarly, including a notable level of CFC-11 dechlorination to CHCl2F immediately 
after CT was consumed (Figure 3.15).   
The treatments with SRS added as the electron donor (Figures 3.16 and 3.17) 
were only effective in terms of CT removal; adjustment of pH did not improve the level 
of activity over treatments without pH adjustment.  Addition of B12 did not improve 
activity over the treatment without B12 added.  pH adjustment was only required once 
(day 107), suggesting that fermentation of the vegetable oil (and therefore generation of 
organic acids) proceeded more slowly than corn syrup.   
Consistent with the results for Set II, the most active treatment for Set III was the 
one that received KB-1© Plus and lactate (Figure 3.18).  The pH level remained in the 
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circumneutral range throughout the 470 days of incubation; it was not necessary to add 
additional bicarbonate beyond what was initially added to the groundwater.  DCM was 
removed below detection in all three bottles.  CF biodegradation occurred at a slower 
rate, with levels decreasing to 0.18-0.25 µmol/bottle (0.35-0.49 mg/L) as of day 471. 
The onset of CF biodegradation appeared to correlate with the onset of reductive 
dechlorination of CFC-11 to CHCl2F after day 452.  As with Set II, the reason for this is 
not clear.  KB-1© Plus is not known for its ability to degrade CFC-11.  In an attempt to 
remove the remaining CF and CFC-11, the microcosms were bioaugmented on day 457 
with the DHM-1 culture + corn syrup solution + B12.  Additional monitoring is needed to 
ascertain if addition of DHM-1 was effective. 
Differing from what was observed with Set II, SRS was an effective electron 
donor for the KB-1© Plus bioaugmentation culture for Set III (Figure 3.19). After 
increasing the frequency and amount of SRS added, there was a modest decrease in CF 
levels while DCM was almost completely removed.  By contrast, there was no significant 
biodegradation of CFC-11. The pH level remained in the circumneutral range throughout 
the 470 days of incubation.  Bioaugmentation with DHM-1 on day 456 was ineffective, 
although further incubation is warranted to validate this observation. 
In addition to halomethanes, the Set III microcosms were evaluated for anions and 
organic acids.  The same groundwater used in Set II was used (but with pH adjustment), 
so the initial nitrate and sulfate levels were the same.  Nitrate was below 0.2 mg/L in the 
groundwater and below detection in all of the microcosm samples.  As with Set II, sulfate 
was measured on three occasions (Figure 3.20a).  Towards the end of the incubation 
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period, 88-99% of the sulfate was consumed in the treatments with lactate and corn syrup 
added, compared to 32-48% in the treatments amended with SRS.  This indicates that 
SRS was not as readily fermented and used as a substrate for sulfate reduction.  The total 
amounts of electron donor added were 2.2-2.5 fold higher than required for sulfate 
reduction and dehalogenation assuming complete oxidation; assuming only a portion of 
the lactate, corn syrup and EVO were fermentable to hydrogen and acetate was not 
utilized for sulfate reduction or dehalogenation, the ratio of electron donor available to 
the demand was still sufficient to meet the demand (Table 3.2).  It is important to note 
that the frequency of electron donor additions was increased significantly after day 321, 
when it was realized that considerable levels of sulfate still remained and the sulfate 
could have been inhibiting dehalogenation.    
Figure 3.20b provides a COD balance for the Set II microcosms on day 476.  This 
encompasses the COD consumption associated with sulfate reduction as well as 
accumulation of acetate and propionate and some lactate remaining in the lactate-
amended treatment.  Other organic acids (succinate and formate) were below detection. 
Although the balances are incomplete, this figure communicates that most of the COD 
consumption was attributable to sulfate consumption and acetate formation. 
Dehalogenation is not shown since it contributed less than 0.05% to the COD balance.   
Table 3.2 also summarizes the target and actual amount of B12 and 
bioaugmentation culture added for Set III.  Repeat doses were made in an attempt to 
stimulate biodegradation activity.    
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3.2 High Concentration Biotic Microcosms 
3.2.1 Controls (Set IV) 
The water control results for the high concentration microcosms (Figure 3.21) 
demonstrate there was no appreciable diffusive loss of CT, CFC-11, CF or DCM 
following 456 days of incubation.  In the autoclaved controls, there was also no 
appreciable decrease in the contaminants (Figure 3.22), indicating that adsorption and 
abiotic activity were insignificant in the high concentration microcosms.      
3.2.2 Live, pH Adjusted (Set V) 
Sodium bicarbonate was used to raise the initial pH of the groundwater from 6.0 
to 6.9.  The pH in the unamended microcosms was checked several times (days 103, 144, 
222, 336, 349, 376, 400, 421, and 436) and remained in the range of 6.7 to 7.2. 
Nevertheless, there was no significant biodegradation of CT, CFC-11, CF or DCM in the 
unamended microcosms (Figure 3.23).   
CT was consumed in all of the donor-amended treatments (Figures 3.24-3.32), 
although at somewhat variable rates.  Among the triplicate lactate-amended microcosms, 
significant activity on CF occurred in bottle #1 between days 297 and 356, in bottle #2 
between days 336 and 437, and in bottle #3 from day 452, with a nearly stoichiometric 
increase in DCM (Figure 3.24).  DCM fermenting microbes were present in bottle #1, 
and DCM declined from 9.2 μmol/ bottle (13.5 mg/L) on day 356 to 1.5 μmol/ bottle (2.3 
mg/L) by day 470. There was only a limited level of CFC-11 dechlorination, with 
accumulation of CHCl2F to nearly 0.2-0.3 µmol/bottle.  The pH level in these bottles 
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remained in the circumneutral range throughout the incubation period, without the need 
for further adjustment.   
In the treatment with corn syrup added, there was no evidence of activity on CFC-
11, CF or DCM following consumption of CT by day 120 (Figure 3.25).  In the treatment 
with B12 added along with corn syrup, CF started to decrease as the frequency and 
amount of amendments was increased after day 300 (Figure 3.26).  It was necessary to 
add bicarbonate to the corn syrup and corn syrup + B12 treatments on nine occasions, 
when the pH fell below 6.5 to a low of 6.2.  The decrease in pH was likely a consequence 
of fermentation of the corn syrup to organic acids.   
The rate of CT consumption in the treatment with SRS added as the electron 
donor (Figure 3.27) was somewhat slower than with lactate and corn syrup.  In the 
treatment with SRS and B12 added, steady decreases in CFC-11 (without accumulation of 
CHCl2F) and CF started after day 325, when the frequency and amount of amendments 
added was increased (Figure 3.28).  Nevertheless, DCM persisted.  Further incubation is 
warranted to determine if the trend with CF is sustained. 
In the treatment that received KB-1© Plus and lactate (Figure 3.29), CF was 
completely removed in bottle #2; DCM increased to 4.6 µmol/bottle before decreasing in 
parallel with the remaining CF to 0.15 µmol (0.23 mg/L).  CF levels decreased abruptly 
in bottles #1 and #3 (to 0.12 µmol [0.23 mg/L] and 0.18 µmol [0.35 mg/L], respectively) 
following an increase in the frequency and amount of lactate additions. When incubation 
ended, DCM levels remained elevated, in spite of addition of more bioaugmentation 
culture on day 473.  Notably, these bottles exhibited only a modest level of reductive 
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dechlorination of CFC-11, with the highest accumulation of CHCl2F reaching 0.6 
µmol/bottle.  The pH level in these bottles remained in the circumneutral range 
throughout the incubation period, without the need for further adjustment. 
As observed with Sets II and III, SRS was not as effective as lactate for the KB-
1© Plus bioaugmentation culture in the high concentration microcosms (Figure 3.30).  
There was no significant biodegradation of CFC-11, CF or DCM through 482 days of 
incubation.  The pH level remained in the circumneutral range throughout most of the 
incubation period; bicarbonate was added three times after measuring a pH slightly below 
6.5. 
In the treatment that received DHM-1 + corn syrup + B12, more than 90% of 
CFC-11 was removed in all three bottles, without accumulation of CHCl2F (Figure 3.31). 
The onset of CF biodegradation corresponded to the decrease in CFC-11 and a much 
higher frequency of corn syrup and B12 additions after day 325.  The 50-70% decrease in 
CF occurred without an increase in DCM, as would be expected with DHM-1.  It was 
necessary to raise the pH several times using sodium bicarbonate, since it fell below 6.5 
(the lowest level was 6.3) as a consequence of fermentation of the corn syrup to organic 
acids.   
The treatment bioaugmented with DHM-1 and supplemented with SRS and B12 
was very effective in biodegrading CFC-11 (below 30 μg/L, without accumulation of 
CHCl2F) and CF (with moderate accumulation of DCM) (Figure 3.32).  In bottles #1 and 
#2, CF was removed below detection while the DCM concentration remained stable at 
0.9 mg/L by day 437. These results were unexpected, since DHM-1 had not previously 
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been evaluated with SRS as the primary growth substrate.  The pH level remained in the 
circumneutral range throughout most of the incubation period; bicarbonate was added on 
days 335 and 399 after measuring a pH below 6.5. 
In addition to halomethanes, the Set V microcosms were evaluated for anions and 
organic acids.  Nitrate was below 0.2 mg/L in the groundwater and below detection in all 
of the microcosm samples.  The initial sulfate concentration in the high concentration 
groundwater was 1,930±160 mg/L.  This compares to 1,800 mg/L based on field 
monitoring data.  As with Sets II and III, sulfate was measured on three occasions (Figure 
3.33a).  Towards the end of the incubation period, 95-99% of the sulfate was consumed 
in the treatments with lactate and corn syrup added, compared to 30-33% in the 
treatments amended with SRS.  This indicates that SRS was not as readily fermented and 
used as a substrate for sulfate reduction.  The total amounts of electron donor added were 
3.7-4.7 fold higher than required for sulfate reduction and dehalogenation assuming 
complete oxidation; assuming only a portion of the lactate, corn syrup and EVO were 
fermentable to hydrogen and acetate was not utilized for sulfate reduction or 
dehalogenation, the ratio of electron donor available to the demand was still sufficient to 
meet the demand (Table 3.2).  It is important to note that the frequency of electron donor 
additions was increased significantly after day 321, when it was realized that 
considerable levels of sulfate still remained and the sulfate could have been inhibiting 
dehalogenation.    
Figure 3.33b provides a COD balance for the Set V microcosms on day 476.  This 
encompasses the COD consumption associated with sulfate reduction as well as 
37 
accumulation of acetate and propionate.  Other organic acids (succinate, formate and 
lactate) were below detection.  Although the balances are incomplete, this figure 
communicates that most of the COD consumption was attributable to sulfate 
consumption and acetate formation.  Dehalogenation is not shown since it contributed 
less than 4% to the COD balance.   
 Table 3.2 also summarizes the target and actual amount of B12 and 
bioaugmentation culture added.  Repeat doses were made to the Set V treatments in an 
attempt to stimulate biodegradation activity.  
3.2.3 Overall Summary of Biotic Microcosm Performance 
 An overall summary for the microcosm results is presented in Table 3.1.  For each 
compound, relative results are given for each of the triplicate bottles (separate by a 
forward slash, “/”).  The extent of degradation in each bottle is designated with a “+” for 
partial degradation, “++” for nearly complete degradation but above ~100 µg/L, and 
“+++” for degradation below drinking water regulations.   
 CT was removed in all but the unamended treatment and controls.  The most 
effective treatments for CFC-11 were bioaugmentation with KB-1© Plus provided with 
lactate as the electron donor, biostimulation with corn syrup and B12, and 
bioaugmentation with DHM-1 and amended with B12 and corn syrup or SRS as donors.  
Nevertheless, complete removal of CFC-11 was not accomplished in any of the 
treatments.  Complete removal of CF was accomplished only in the Set V 
bioaugmentation treatment with DHM-1 and amended with SRS + B12.  Other treatments 
that were nearly as effective for CF included bioaugmentation with KB-1© Plus and 
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lactate as the electron donor and bioaugmentation with DHM-1 and amended with B12 
and corn syrup or SRS as donors.  Complete removal of DCM occurred in the Sets II and 
III microcosms that were bioaugmented with KB-1© Plus and lactate as the electron 
donor.  DCM was more persistent in the Set V microcosms, with the most complete 
removal occurring in the microcosms that were bioaugmented with DHM-1 and amended 
with SRS + B12.   
3.3 High Concentration Abiotic/Biotic Microcosms 
There was no significant decrease in CT, CFC-11, CF or DCM in the unamended 
microcosms (Figure 3.34) or in the treatments amended with sodium dithionite (Figure 
3.35) and titanium(III) citrate + corn syrup + B12 (Figure 3.36), during 83 days of 
incubation. The redox potential in the unamended bottles was above -110 mV, based on 
the color of the resazurin (pink). Five days after adding electron donor, the color of the 
groundwater in the sodium dithionite amended bottles and titanium(III) citrate + corn 
syrup + B12 amended bottles changed from light pink to clear, indicating a redox level 
below -110 mV.  
CT was degraded to below detection in the ZVI amended microcosms within 7 
days of incubation (Figure 3.37). By day 83, CF decreased to below detection in ZVI 
bottle #1, and approximately 0.11 mg/L in bottles #2 and #3.  More than 90% of the 
CFC-11 was consumed over this interval. As a consequence of CF and CFC-11 
transformation, DCM increased (on average) from 1.3 to 3.4 mg/L (0.91 to 2.31 
µmol/bottle) and CHCl2F increased from 0.33 to 1.7 mg/L (0.23 to 1.17 µmol/bottle).  On 
day 26, KB-1© Plus was added with the intent of biodegrading the remaining DCM. 
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However, no activity was observed through day 83.  CHCl2F also persisted through the 
end of the experiment.  Furthermore, analysis of headspace samples indicated an increase 
in six unidentified peaks, at retention times ranging from 2.4 to 8.9 min.   
In the treatment amended with calcium polysulfide, CT was degraded to below 
detection within 17 days (Figure 3.38).  DCM decreased by an average of 95% over the 
83 day incubation period.  However, there was no significant decrease in CFC-11 or CF.  
3.4 CF Biodegradation Products from KB-1© Plus 
Four treatments were prepared to elucidate the end product distribution from CF 
by KB-1© Plus.  Figure 3.39 presents a representative headspace monitoring result one of 
the medium control bottles (i.e., no culture added), which shows that there was no 
appreciable loss of CF during 7 days of incubation.  A representative result for a bottle 
that received CF, 14C-CF, and culture is shown in Figure 3.40.  This is designated as one 
of the “intermediate, no BES” bottles, since it was sacrificed for analysis of the 14C 
distribution after the CF was consumed but some of the DCM still remained, and no BES 
was added.  The initial amount of CF (~16 µmol) equates to an aqueous phase 
concentration of 14.9 mg/L.  Accumulation of DCM was not stoichiometric, suggesting 
that it was being fermented as it was being formed from CF.  Figure 3.41 provides a 
representative result for the bottles that were treated in the same manner except that they 
were not sacrificed to determine the 14C distribution until after the CF and DCM were 
consumed.  These bottles are therefore designated as “final, no BES,” and no BES was 
added.  Lastly, Figure 3.42 provides a representative result for the bottles that received 
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BES and were not sacrificed to determine the 14C distribution until after the CF and DCM 
were consumed.  These bottles are therefore designated as “final, BES.”     
The distribution of 14C from biodegradation of 14C-CF is summarized in Figure 
3.43.  The results represent averages of 3 to 9 bottles evaluated during three separate 
experiments. Nearly complete recovery of 14C-CF in the medium control (96%) 
confirmed the high purity of the 14C-CF added to all of the bottles and the lack of any 
significant abiotic transformation in the presence of mineral medium.  14CO2 was by far 
the most significant product in the treatments with KB-1© Plus present, ranging from 59-
78% of the initial 14C-CF added. 14C-DCM was significant only in bottles that were 
sacrificed after CF was consumed but before all of the DCM was consumed.  It is notable 
that there was also significant accumulation of 14CO2 in these bottles, even before the 
DCM was completely consumed.  The next highest category of identifiable products was 
14C-NSR, which includes organic acids; however, the maximum level of NSR was only 
5%.  This indicated that the principal biodegradation pathway for anaerobic 
biodegradation of CF by KB-1© Plus is via mineralization, rather than direct 
incorporation of carbon from DCM into organic acids.  NSR from bottles that 
accumulated the highest levels was subjected to fractionation by HPLC.  The only 
fraction that yielded a detectable level of 14C activity corresponded to acetate.    
The “unaccounted” fraction in Figure 3.43 represents 14C that was present in the 
bottles but could not be assigned to the other identifiable categories (i.e., CF, DCM, CO2, 
or NSR).  Losses were calculated based on the 14C recovered when the bottles were 
sacrificed compared to the 14C initially added.  The magnitude of losses increased with 
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incubation time.  Although notable, losses were minor in comparison to the amount of 
14CO2 formed.   
Conversion of CF to CO2 is a net oxidation, indicating that the electron 
equivalents from this process have to go somewhere.  Reductive dechlorination of CF to 
DCM is one potential disposition for the electron equivalents; another possibility is 
release of hydrogen during fermentation of DCM.  This option was explored with a single 
bottle (not enough culture was available at the time to run replicates) to which only DCM 
was added (i.e., no other electron donor).  After the DCM was consumed, another dose 
was added along with BES, in order to prevent electron equivalents from being used to 
form methane.  As shown in Figure 3.44, the rate of DCM biodegradation slowed after 
adding the BES but it did go to completion.  As DCM was biodegraded, hydrogen 
accumulated and then decreased.  Additional experiments are needed to confirm the 
occurrence of hydrogen formation during DCM fermentation.  Nevertheless, the 
preliminary results strongly suggest hydrogen formation is one way to account for the 
electron equivalents for DCM mineralization.  What becomes of the hydrogen after it is 




Results from the downgradient microcosms indicate that the most effective 
treatments for CF were bioaugmentation with KB-1© Plus provided with lactate as the 
electron donor, biostimulation with corn syrup and B12, and bioaugmentation with DHM-
1 and amended with B12 and corn syrup or SRS as donors.  Nevertheless, complete 
removal of CFC-11 was not accomplished in any of the treatments.  Accumulation of 
CHCl2F was lower in the Set V microcosms that were bioaugmented with DHM-1.  It is 
unclear how significant a factor CHCl2F will be when deciding on a remediation strategy. 
Minimizing its accumulation is desirable, yet there are no regulations that target this 
dechlorination product from CFC-11.   
Complete removal of CF was accomplished only in the Set V bioaugmentation 
treatment with DHM-1 and amended with SRS + B12.  SRS performed better as a primary 
substrate for the DHM-1 culture than corn syrup.  This was unexpected, since DHM-1 
had not previously been evaluated with SRS; it was developed and maintained on corn 
syrup.  In practice, SRS is preferable since it is longer lasting and in this study was less 
prone to depressing the pH than corn syrup.  The treatment with DHM-1 and corn syrup 
was nearly as effective, but did not quite reach the target of 70 µg/L, the maximum 
allowed in drinking water. 
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Bioaugmentation with KB-1© Plus and lactate as the electron donor nearly 
reached the treatment objective for CF, although activity on CF had a tendency to stall. 
The reason for this is unclear.  Since this occurred in both the lower and higher 
concentration microcosms, the high concentration of CF in the Set V bottles is not likely 
the only explanation.  The presence of CFC-11 may be a key factor; no literature was 
found that evaluated the effect of CFC-11 on the performance of Dehalobacter.  Once CF 
levels decreased in the downgradient microcosms with  KB-1© Plus added, reduction of 
CFC-11 commenced, although CHCl2F was the predominant product.   
The treatment that was most effective for DCM was bioaugmentation with KB-1© 
Plus.  This is consistent with the known presence of DCM-fermenting Dehalobacter spp. 
in the culture.  However, KB-1© Plus was less effective in the higher concentration 
microcosms on DCM, perhaps due to inhibition caused by lingering levels of CFC-11 
and/or CF.  
Sulfate appears to have played a central role in the progress of the microcosms. 
The frequency and amount of electron donor additions was increased after it was 
discovered that high sulfate levels persisted even after 300 days of incubation.  This is 
unfortunate because the sulfate levels are significantly elevated in the groundwater 
(~2,000-3,000 mg/L), thereby creating a very high COD demand.  Shan et al. (7) 
observed similarly long lag times in establishing dehalogenation activity in microcosms 
with initially high sulfate levels.  As sulfate decreased, biodegradation of CFC-11 got 
underway in many treatments and CF started to decrease as well.   
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pH adjustment was considered essential for the upgradient location because the 
groundwater pH is close to or below 6, which is regarded as unfavorable for application 
of bioremediation.  pH has been given considerable attention in other studies.  For 
example, Pseudomonas stuzeri strain KC was employed for biodegradation of CT at the 
Schoolcraft site in Michigan.  Its effectiveness was restricted by low pH that resulted 
from discontinued pH adjustment (28).   Microbial utilization of corn syrup via 
fermentation and SRS via β-oxidation produces organic acids, which often suppresses the 
pH and can lead to inhibition of bioremediation. pH adjustment facilitated DCM 
degradation in this study, when comparing the two BA/A + SRS treatments in Sets II and 
III; however, the overall benefit of adjusting pH for the downgradient microcosms was 
limited.  For example, the low pH in Set II BA/A + SRS microcosms (~5.8) was expected 
to be problematic, yet biodegradation of DCM and CF did occur. Further work is needed 
to characterize the effect of pH on the KB-1© Plus culture.   
The benefits of using B12 as a catalyst for anaerobic biodegradation of CF have 
been reported.  B12 shifts the degradation pathway away from reductive dechlorination to 
hydrolytic dechlorination to CO, which is then converted to CO2 and organic acids (8, 
29).  B12 had a similar catalytic effect on CFC-11 transformation with the DHM-1 
enrichment culture (2). However, the effect of B12 on CF and CFC-11 biotransformation 
products in this study were somewhat different. In the presence of B12, CF transformation 
resulted in significant increases in daughter products in Set V BA/B SRS + B12 bottle #2.  
Conversely, in Set V SRS + B12 and Set V BA/B + CS + B12 microcosms, transformation 
of CF and CFC-11 by DHM-1 did not result in a significant amount of daughter products 
45 
accumulation; further investigation is needed to reveal these different responses to DHM-
1 bioaugmentation. 
In the microcosm study by Shan et al. (7), the order by which halomethanes were 
consumed was CT, followed by CFC-11 and then CF. During the research for this thesis, 
biotransformation of CT occurred in all microcosms before any other halogenated 
compounds. However, the order by which CFC-11, CF and DCM were consumed varied: 
In the Set II BA/A Lac bottles, the Set V BA/A Lac bottles, and Set V Lac bottles, CF 
was transformed to DCM before CFC-11 biotransformation occurred. Apparently the 
Dehalobacter responsible for CF and DCM removal were not fully inhibited by CFC-11, 
yet they exhibited much lower activity on CFC-11.    
CF has been shown to inhibit acetotrophic sulfate reduction (30). Nevertheless, 
sulfate consumption did occur in the presence of CF during this study.  Based on sulfate 
consumption of 630 mg/L, the amount of sulfide generated would be 6.5 mmol/L.  It is 
unlikely this amount was present in the aqueous phase, however, since sulfide tends to 
react with soil and/or precipitates with various metals, especially Fe(II).  The 
effectiveness of DHM-1 depends in part on having sulfide present in the aqueous phase; 
its role is not yet known, but it may be needed to re-reduce the cobalt in B12 after it reacts 
with CT, CF and CFC-11.   
The results of this study are the first to report an end product mass balance for 
biodegradation of CF by the KB-1© Plus culture.  Using 14C-CF, it was shown that the 
principal product from anaerobic biodegradation of CF by KB-1© Plus was CO2.  CO2 
accumulated in treatments with and without BES added, and significant amounts 
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accumulated even when CF was consumed but some DCM remained.  This suggests that 
the pathway for DCM metabolism in the KB-1© Plus culture is different from that 
reported for Dehalobacterium formicoaceticum, which directly incorporates the carbon in 
DCM into formate and acetate.  A proposed pathway for biodegradation of CF by the 
KB-1© Plus culture is shown in Figure 4.1.  The disposition of reducing equivalents 
gained during fermentation of DCM is not yet known, although a preliminary experiment 
confirmed that hydrogen accumulates transiently as DCM is consumed.  It seems likely 
that the reducing equivalents formed from DCM are consumed for methane production 
and/or organic acid formation.  These products were not 14C-labeled most likely because 
the 14CO2 that is generated enters a large pool of bicarbonate in the mineral medium, such 
that any bicarbonate used for methane or organic acid formation had a low percentage of 
labeled compound (i.e., the 14CO2 was diluted out).  In theory, another disposition for the 
reducing equivalents from fermentation of DCM is reductive dechlorination of CF to 
DCM.  The fact that DCM conversion appears to proceed before all of the CF is 
consumed lends support to this hypothesis.  However, additional experimentation is 
needed to determine if this is a sustainable process.  Lee et al. (11) indicated in their 
studies that CF inhibited DCM fermentation and therefore CF reduction needed to be 
completed before DCM fermentation started.  It remains to be seen if the same is true for 
the KB-1© Plus culture.   
 The ZVI treatment was the most effective among the abiotic treatments evaluated 
for this microcosm study. Justica-Leon et al. (20) reported that a ZVI barrier removed 
~58-90% of CT across three transects; however CF and DCM increased downgradient of 
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the barrier. Microcosms using the downgradient water achieved detoxification of the CF 
through bioaugmentation. A similar approach was evaluated in the current study, by 
bioaugmenting the ZVI microcosms with the KB-1© Plus culture after the CT, CFC-11 
and CF were consumed by the ZVI.  However, the accumulated daughter products 
(DCM, HCFC-21, and several unidentified volatiles) persisted. Additional research is 
needed to understand why the KB-1© Plus culture did not remove the remaining DCM 
generated during ZVI treatment of CT and CF.   
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CHAPTER FIVE 
5.0 CONCLUSIONS AND RECOMMENDATIONS 
Based on the results of this research, the following conclusions were reached: 
1) All of the donor-amended treatments removed CT in the low and high
concentration microcosms.  Although the rates differed, removal of CT occurred 
consistently and is not a major factor in selection of a bioremediation strategy.   
2) For the downgradient portion of the plume, the most effective bioremediation
strategy for CF and DCM is bioaugmentation with KB-1© Plus amended with lactate.  pH 
control does not appear to be necessary; the Set II (no pH control) and Set III (with pH 
control) treatments performed similarly.  Somewhat unexpected was the robust 
performance of the pH adjusted microcosms that received lactate as an electron donor. 
These results suggest that the site contains indigenous Dehalobacter spp. that are capable 
of organohalide respiration of CF to DCM and fermentation of DCM to nonchlorinated 
products.   
3) Although bioaugmentation with KB-1© Plus and lactate was most effective for CF
and DCM in the downgradient portion of the plume, CFC-11 biodegradation was 
occurred later and resulted in mainly CHCl2F.  Bioaugmentation with DHM-1, corn 
syrup, and B12, after the CF and DCM were mostly degraded, did not elicit a response, 
although additional monitoring is needed to assess the outcome.   
4) For the upgradient portion of the plume, the most effective bioremediation
strategy for CF and DCM was bioaugmentation with DHM-1, SRS, and B12.  This 
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treatment achieved complete removal of CF and significant removal of CFC-11 and 
DCM. Removal of the DCM suggests that the site contains an indigenous population of
anaerobic microbes capable of fermenting DCM as a sole substrate.  Bioaugmentation 
with the KB-1© Plus and lactate also showed promise for the upgradient zone, although 
additional incubation is needed to confirm consumption of DCM formed from CF.  Also, 
KB-1© Plus was less effective in removing CFC-11 in the upgradient microcosms; 
follow-up bioaugmentation with DHM-1 may be feasible to address the CFC-11.      
5) The high level of sulfate in the groundwater created a high demand for electron
donor. (Appendix E)  Significant improvement in the rate of CFC-11, CF, and DCM 
biodegradation ensued following an increase in the frequency and amount of electron 
donor additions after 300 days of incubation, commensurate with the onset of sulfate 
reduction.  This lag could have been shortened significantly by following a much more 
aggressive schedule of electron donor additions earlier in the incubation period.  Lactate 
and corn syrup were more effective in establishing sulfate reducing conditions than SRS. 
It is likely that the initially slow rate of electron donor additions resulted in wasteful 
additions of bioaugmentation culture and B12; these additions should have been made 
only after sulfate reduction was well established.  The sulfide generated from sulfate 
reduction likely created the low redox conditions that are conducive to halomethane 
degradation.   
6) The most effective abiotic treatment involved the use of ZVI; after approximately
three months of incubation, the CT, CF, and CFC-11 were removed.  However, DCM and 
CHCl2F persisted; an attempt to biodegrade DCM by augmenting with KB-1© Plus was 
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ineffective, for reasons that are not yet known.  Also, unknown volatile compounds 
accumulated in the ZVI-amended microcosms.  While ZVI was faster than the biotic 
treatments in this study, this advantage would likely diminish if the biotic-only treatments 
had received more aggressive additions of electron donor from the outset.   
7) Using 14C-CF, it was shown that the principal product from anaerobic
biodegradation of CF by KB-1© Plus was CO2.  This is the first report to demonstrate a 
complete mass balance on the products from CF biodegradation by KB-1© Plus, and to 
show that these products are nonhazardous.  CO2 accumulated in treatments with and 
without BES added, and significant amounts accumulated even when CF was consumed 
but some DCM remained.  This suggests that the pathway for DCM metabolism in the 
KB-1© Plus culture is different from that reported for Dehalobacterium formicoaceticum, 
which directly incorporates the carbon in DCM into formate and acetate.  The disposition 
of reducing equivalents gained during fermentation of DCM is not yet known, although a 
preliminary experiment confirmed that hydrogen accumulates transiently as DCM is 
consumed.  It seems likely that the reducing equivalents formed from DCM are 
consumed for methane production and/or organic acid formation.  These products are not 
14C-labeled most likely because the 14CO2 that is generated enters a large pool of 
bicarbonate in the mineral medium, such that any bicarbonate used for methane or 
organic acid formation has a low percentage of labeled compound (i.e., the 14CO2 is 
diluted out).   
The following recommendations are offered for further study: 
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1) A better understanding is needed for the impact of sulfate on anaerobic
biodegradation of halomethanes.  
2) Accumulation of organic acids during DCM fermentation by the KB-1© Plus
culture should be confirmed.  This will require consuming a sufficiently high amount of 
DCM so that the unlabeled organic acids can be quantified by HPLC.  Methanogenesis 




Table 2.1. Experimental design for Sets I through V microcosms. 
Treatment Set Soil/GW Location ID Description Amendment 
Halomethane 
Concentration 
1 I NA Water control None (DDI water only) Low - medium 
2 I AS-MW-65 / AS-MW-65 Autoclaved control None Low - medium 
3 II AS-MW-65 / AS-MW-65 No pH adjustment None Low - medium 
4 II AS-MW-65 / AS-MW-65 No pH adjustment Lactate (basis for comparison w/wout bioaug) Low - medium 
5 II AS-MW-65 / AS-MW-65 No pH adjustment Corn syrup (compare to w/B12) Low - medium 
6 II AS-MW-65 / AS-MW-65 No pH adjustment Corn syrup and B12 Low - medium 
7 II AS-MW-65 / AS-MW-65 No pH adjustment SRS (lactate and longer lasting substrate) Low - medium 
8 II AS-MW-65 / AS-MW-65 No pH adjustment SRS and B12 (B12 in molar ratio with SRS) Low - medium 
9 II AS-MW-65 / AS-MW-65 No pH adjustment Bioaugmentation (A) and lactate Low - medium 
10 II AS-MW-65 / AS-MW-65 No pH adjustment Bioaugmentation (A) and SRS Low - medium 
11 III AS-MW-65 / AS-MW-65 pH adjustment None Low - medium 
12 III AS-MW-65 / AS-MW-65 pH adjustment Lactate Low - medium 
13 III AS-MW-65 / AS-MW-65 pH adjustment Corn syrup Low - medium 
14 III AS-MW-65 / AS-MW-65 pH adjustment Corn syrup and B12 Low - medium 
15 III AS-MW-65 / AS-MW-65 pH adjustment SRS Low - medium 
16 III AS-MW-65 / AS-MW-65 pH adjustment SRS and B12 Low - medium 
17 III AS-MW-65 / AS-MW-65 pH adjustment Bioaugmentation (A) and lactate Low - medium 
18 III AS-MW-65 / AS-MW-65 pH adjustment Bioaugmentation (A) and SRS Low - medium 
19 IV NA Water control None (DDI water only) High 
20 IV AS-MW-65 / AS-MW-63_110 Autoclaved control None High 
21 V AS-MW-65 / AS-MW-63_110 pH adjustment None High 
22 V AS-MW-65 / AS-MW-63_110 pH adjustment Lactate High 
23 V AS-MW-65 / AS-MW-63_110 pH adjustment Corn syrup High 
24 V AS-MW-65 / AS-MW-63_110 pH adjustment Corn syrup and B12 High 
25 V AS-MW-65 / AS-MW-63_110 pH adjustment SRS High 
26 V AS-MW-65 / AS-MW-63_110 pH adjustment SRS and B12 High 
27 V AS-MW-65 / AS-MW-63_110 pH adjustment Bioaugmentation (A) and lactate High 
28 V AS-MW-65 / AS-MW-63_110 pH adjustment Bioaugmentation (A) and SRS High 
29 V AS-MW-65 / AS-MW-63_110 pH adjustment Bioaugmentation (B) and corn syrup and B12 High 
30 V AS-MW-65 / AS-MW-63_110 pH adjustment Bioaugmentation (B) and SRS and B12 High 
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Table 3.1 Summary of results for Sets I through V microcosms. 
Treatment Set Amendment 
Halomethane 
concentration CT CFC-11 CF DCM 
1 I None (DDI water only) Low - medium  -/-/-  -/-/-  -/-/-  -/-/- 
2 I None Low - medium  -/-/-  -/-/-  -/-/-  -/-/- 
3 II None Low - medium  -/-/-  -/-/-  -/-/-  -/-/- 
4 II Lactate (basis for comparison w/wout 
 
Low - medium +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
5 II Corn syrup (compare to w/B12) Low - medium +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
6 II Corn syrup and B12 Low - medium +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
7 II SRS (lactate and longer lasting substrate) Low - medium +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
8 II SRS and B12 (B12 in molar ratio with SRS) Low - medium +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 





 10 II Bioaugmentation (A) and SRS Low - medium +++/+++/+++ 
 
 -/-/-  ++/-/++  ++/+++/++ 
11 III None Low - medium  -/-/-  -/-/-  -/-/-  -/-/- 
12 III Lactate Low - medium +++/+++/+++ 
 
 +/+/++  +/+/+++ +++/+++/++
 13 III Corn syrup Low - medium +++/+++/+++ 
 
 ++/++/++  -/-/-  -/-/- 
14 III Corn syrup and B12 Low - medium +++/+++/+++ 
 
 ++/++/++  -/-/-  -/-/- 
15 III SRS Low - medium +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
16 III SRS and B12 Low - medium +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
17 III Bioaugmentation (A) and lactate Low - medium +++/+++/+++ 
 
 ++/++/++  ++/++/++ +++/+++/+++ 
 18 III Bioaugmentation (A) and SRS Low - medium +++/+++/+++ 
 
 -/-/-  +/+/+  +++/+++/++ 
19 IV None (DDI water only) High  -/-/-  -/-/-  -/-/-  -/-/- 
20 IV None High  -/-/-  -/-/-  -/-/-  -/-/- 
21 V None High  -/-/-  -/-/-  -/-/-  -/-/- 
22 V Lactate High +++/+++/+++ 
 
 -/-/-  ++/++/++  -/-/- 
23 V Corn syrup High +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
24 V Corn syrup and B12 High +++/+++/+++ 
 
 ++/++/+  -/-/-  -/-/- 
25 V SRS High +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
26 V SRS and B12 High +++/+++/+++ 
 
 ++/++/+  ++/++/+  -/-/- 
27 V Bioaugmentation (A) and lactate High +++/+++/+++ 
 
 -/+/-  ++/++/++  -/++/- 
28 V Bioaugmentation (A) and SRS High +++/+++/+++ 
 
 -/-/-  -/-/-  -/-/- 
29 V Bioaugmentation (B) and corn syrup and B12 High +++/+++/+++ 
 
++/++/++ ++/++/++  -/-/- 
30 V Bioaugmentation (B) and SRS and B12 High +++/+++/+++  ++/++/++ +++/+++/+++ ++/++/- 
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Table 3.2.  Summary of electron donor, B12, and bioaugmentation culture for Sets II, III, and V microcosms.  
Electron Donor (meq/bottle) B12 (µmol/bottle) Bioaug. Culture 
(mL/bottle) 




Completec Target Actual Initial Total 
3 Set II Lac 13.0 13.97 41.92 - - - - 
4 Set II CS 13.0 14.05 42.14 - - - - 
5 Set II CS B12 13.0 14.05 42.14 0.016 0.080 - - 
6 Set II SRS 13.0 14.58 42.12 - - - - 
7 Set II SRS B12 13.0 14.58 42.12 0.016 0.080 - - 
8 Set II BA/A Lac 13.0 15.38 46.14 - - 0.10 1.80 
9 Set II BA/A SRS 13.0 15.95 46.39 - - 0.10 1.80 
12 Set III Lac 13.0 13.97 41.92 - - - - 
13 Set III CS 13.0 14.05 42.14 - - - - 
14 Set III CS B12 13.0 14.05 42.14 0.016 0.080 - - 
15 Set III SRS 13.0 14.58 42.12 - - - - 
16 Set III SRS B12 13.0 14.58 42.12 0.016 0.080 - - 
17 Set III BA/A Lac 13.0 15.39 46.18 - - 0.10 1.80 
18 Set III BA/A SRS 13.0 15.95 46.39 - - 0.10 1.80 
22 Set V Lac 8.5 15.92 47.76 - - - - 
23 Set V CS 8.5 16.03 48.10 - - - - 
24 Set V CS B12 8.5 16.03 48.10 0.24 1.20 - - 
25 Set V SRS 8.5 16.58 47.89 - - - - 
26 Set V SRS B12 8.5 16.58 47.89 0.24 1.20 - - 
27 Set V BA/A Lac 8.5 13.28 39.85 - - 0.10 1.80 
28 Set V BA/A SRS 8.6 16.72 48.31 - - 0.10 1.80 
29 Set V BA/B CS B12 8.5 16.19 48.58 0.24 1.44 0.10 1.80 
30 Set V BA/B SRS B12 8.5 16.72 48.31 0.24 1.44 0.10 1.80 
a Based on the demand for CF reduction to DCM and sulfate reduction to sulfide. 
b Based on assumed hydrogen yields of 4 meq/mmol lactate, 8 meq/mmol corn syrup, and 108 meq/mmol EVO.  
























Figure 1.1.  Pathways for anaerobic biodegradation of CF and DCM.  Metabolic processes are 
indicated by solid lines; cometabolic pathways are indicated by dashed lines.  Reductive dechlorination 
of CF to DCM may occur metabolically or cometabolically.  [H] = H+ + e-. 
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Figure 3.4.  Results for Set II microcosms (LAC) amended with lactate (indicated by arrows); a) 





































































































































Figure 3.5.  Results for Set II microcosms (CS) amended with corn syrup (indicated by arrows); 






































































































































Figure 3.6.  Results for Set II microcosms (CS+B12) amended with corn syrup (indicated by 





































































































































Figure 3.7.  Results for Set II microcosms (SRS) amended with vegetable oil (indicated by 






































































































































Figure 3.8.  Results for Set II microcosms (SRS+B12) amended with vegetable oil (indicated by 

























































































































Figure 3.9.  Results for Set II microcosms (BA/A-LAC) amended with lactate (indicated by 
arrows), B12(red diamond), and bioaugmented with KB-1© Plus (blue diamonds) and DHM-








































































































































Figure 3.10.  Results for Set II microcosms (BA/A-SRS) amended with vegetable oil (indicated 
by arrows), B12 (red diamond), and bioaugmented with KB-1© Plus (blue diamonds) and DHM-1 
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Figure 3.11. Sulfate and volatile fatty acids (VFAs) analysis for Set II microcosms; a) sulfate concentrations for three different 
incubation days  in representative bottles; b) VFAs and sulfate reduction (presented in mg COD/L) following 476 days of incubation 










































































































































































Figure 3.13.  Results for Set III microcosms (LAC) amended with lactate (indicated by arrows); 





































































































































Figure 3.14.  Results for Set III microcosms (CS) amended with corn syrup (indicated by arrows) 
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Figure 3.15.  Results for Set III microcosms (CS+B12) amended with corn syrup (indicated by 
arrows), B12 (red diamonds), and NaHCO3 for pH adjustment (orange squares); a) bottle #1; b) 




































































































































Figure 3.16.  Results for Set III microcosms (SRS) amended with vegetable oil (indicated by 






































































































































Figure 3.17.  Results for Set III microcosms (SRS+B12) amended with vegetable oil (indicated 




































































































































Figure 3.18.  Results for Set III microcosms (BA/A-LAC) amended with lactate (indicated by 
arrows), B12 (red diamond), and bioaugmented with KB-1© Plus (blue diamonds) and DHM-1 








































































































































Figure 3.19.  Results for Set III microcosms (BA/A-SRS) amended with vegetable oil (indicated 
by arrows), B12 (red diamond), NaHOC3 for pH adjustment (orange square), and bioaugmented 
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Figure 3.20. Sulfate and VFAs analysis for Set III microcosms; a) sulfate concentrations for three different incubation days  in 
representative bottles; b) VFAs and sulfate reduction (presented in mg COD/L) following 476 days of incubation in representative 






































O42− → HS− 





Figure 3.21.  Results for Set IV water control microcosms (WC); a) bottle #1; b) bottle #2; and c) 
























































































































Figure 3.22.  Results for Set IV autoclaved control microcosms (AC); a) bottle #1; b) bottle #2; 



















































































































































































































































Figure 3.24.  Results for Set V microcosms (LAC) amended with lactate (indicated by arrows); 









































































































































Figure 3.25.  Results for Set V microcosms (CS) amended with corn syrup (indicated by arrows) 








































































































































Figure 3.26.  Results for Set V microcosms (CS+B12) amended with corn syrup (indicated by 
arrows), B12 (red diamonds) and NaHCO3 for pH adjustment (orange squares); a) bottle #1; b) 














































































































































Figure 3.27.  Results for Set V microcosms (SRS) amended with vegetable oil (indicated by 
arrows) and NaHCO3 for pH adjustment (orange squares); a) bottle #1; b) bottle #2; and c) bottle 











































































































































Figure 3.28.  Results for Set V microcosms (SRS+B12) amended with vegetable oil (indicated by 
arrows), B12 (red diamonds), and NaHCO3 for pH adjustment (orange squares); a) bottle #1; b) 




























































































































Figure 3.29.  Results for Set V microcosms (BA/A-LAC) amended with lactate (indicated by 
arrows) and bioaugmented with KB-1© Plus (blue diamonds); a) bottle #1; b) bottle #2; and c) 


































































































































Figure 3.30.  Results for Set V microcosms (BA/A-SRS) amended with vegetable oil (indicated 
by arrows), NaHCO3 for pH adjustment (orange squares) and bioaugmented with KB-1© Plus 


















































































































  88  
 
 
Figure 3.31.  Results for Set V microcosms (BA/B-CS+B12) amended with corn syrup (indicated 
by arrows), B12 (red diamonds), NaHCO3 for pH adjustment (orange squares), and bioaugmented 





































































































































Figure 3.32.  Results for Set V microcosms (BA/B-SRS+B12) amended with vegetable oil 
(indicated by arrows) and B12 (red diamonds) and bioaugmented with DHM-1 (blue diamonds); 
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Figure 3.33. Sulfate and VFAs analysis for Set V microcosms; a) sulfate concentrations for three different incubation days  in 
representative bottles; b) VFAs and sulfate reduction (presented in mg COD/L) following 476 days of incubation in representative 





































SO42− → HS− 













































Figure 3.34.  Results for abiotic unamended microcosms (A-UN); a) bottle #1; b) bottle #2; and 




































































































































































Figure 3.35.  Results for abiotic microcosms (NaD) amended with sodium dithionite (indicated 





































































































































































Figure 3.36.  Results for abiotic microcosms (Ti+Glu+B12) amended with titanium chloride, 







































































































































































Figure 3.37.  Results for abiotic/biotic microcosms (ZVI) amended with zero valent iron 
(indicated by arrows) and bioaugmented with KB-1© Plus (blue diamond); a) bottle #1; b) bottle 








































































































































































Figure 3.38.  Results for abiotic microcosms (CaSX) amended with calcium polysulfide 































































































































Figure 3.39 Representative results for CF and 14C-CF in a control bottle with MSM but no 









Figure 3.40 Representative results for biodegradation of CF and 14C-CF by the KB-1© Plus 
culture.  The bottles were sacrificed to evaluate the distribution of 14C after the CF was 
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Figure 3.41 Representative results for biodegradation of CF and 14C-CF by the KB-1© Plus 
culture.  The bottles were sacrificed to evaluate the distribution of 14C after the CF and DCM 






Figure 3.42 Representative results for biodegradation of CF and 14C-CF by the KB-1© Plus 
culture in the presence of BES.  The bottles were sacrificed to evaluate the distribution of 14C 
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Figure 3.43 Distribution of 14C from treatments with 14C-CF added.  Bars represent averages for 
3 medium control bottles, 6 intermediate and no BES bottles, 9 final and no BES bottles, and 6 
final with BES added bottles.  Error bars are standard deviations.  Percentages are in relation to 







Figure 3.44 DCM biodegradation in a single bottle with KB-1© Plus. BES was added on day 8 























































































Figure 4.1. Proposed pathway for the metabolism of DCM by 
Dehalobacter sp. in KB-1
©
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Appendix A 
MODIFIED MSM PREPARATION 
  
Reagents and stock solutions needed for the medium:  
  
-  Phosphate buffer 
In a 100 mL volumetric flask add 5.25 g K2HPO4.  Fill to 100 mL with DDI water.  
 
 
- Salt solution  
In a 100 mL volumetric flask add:  
5.35 g NH4Cl  
0.46976 g CaCl2·2H2O  
0.17787 g FeCl2·H2O  
Fill to 100 mL with DDI water.  
  
- Trace metals solution  
In a 100 mL volumetric flask add:  
0.03 g H3BO3   
0.0211 g ZnSO4·7H2O  
0.075 g NiCl2 ·6H2O  
0.1 g MnCl2·4H2O  
0.01 g CuCl2·2H2O  
0.15 g CoCl2 ·6H2O  
0.002 g Na2SeO3   
0.01 g Al2(SO4)3·16H2O   
1 mL HCl, 37%.    
Fill to 100 mL with DDI water.  
  
- Magnesium sulfate solution  
In a 100 mL volumetric flask add 6.25 g MgSO4·7H2O.  Fill to 100 mL with DDI water.  
  
- Redox solution  
In a 10 mL volumetric flask add 0.01 g resazurin.  Fill to 10 mL with DDI water.  
 
- Bicarbonate solution  
In a 500 mL volumetric flask add 8 g NaHCO3.  Fill to 500 mL with DDI water.  
 
  
- Yeast extract solution  
In a 100 mL volumetric flask add 0.5 g yeast extract.  Fill to 100 mL with DDI water.  
 
- Ferrous sulfide  
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For 1 L of media, weigh into separate glass vials: 
0.24 g of Na2S·9H2O   
0.1448 g FeCl2·H2O  
  
Media Preparation  
  
1)  In a 1 L bottle add:  
            10 mL phosphate solution  
            10 mL salt solution  
            2 mL trace metals solution  
            2 mL magnesium sulfate solution  
            1 mL redox solution  
            965 mL DDI water  
  
2)  Autoclave the above solution and allow to cool.  
  
3)  Add:  10 mL filter sterilized yeast extract  
    50 mL filter sterilized sodium bicarbonate solution. 
  
4)  Transfer the bottle to the glove box along with the vials of sodium sulfide and ferrous 
chloride and 10 mL of sterile DDI water. When the O2 reaches zero, add the 0.24 g of 
Na2S·9H2O and rinse the vial with ~5 mL of sterile DDI water. Wait until the media turns 
from pink to clear.    
  
5)  Then add the 0.1448 g FeCl2·H2O.  Rinse the vial with ~5 mL of sterile DDI water.    
  
6)  After dispensing the media, remove bottles from the glove box and purge the 
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Appendix B 
ELECTRON DONOR DOSING 
Part 1: Biotic-Only Microcosms 
 
The amount of electron donor to be added is based on the objectives for the various 
microcosms.  Two basic scenarios are being evaluated with respect to CF, which is the 
highest concentration contaminant: metabolism and cometabolism.  Metabolism refers to 
halorespiration of CF to DCM, followed by fermentation of DCM (serving as a sole 
carbon and energy source) to organic acids.  Cometabolism refers to a fortuitous process 
whereby microbes growing on a primary substrate then convert a non-growth substrate to 




Corn syrup (CS) and SRS were evaluated for use as primary substrates to drive 
cometabolism, with and without B12 added.  This applies to: 
 
• Set II, treatments 5, 6, 7 and 8 
• Set III, treatments 13, 14, 15 and 16 
• Set V, treatments 23, 24,25, 26,  
• Set V, bioaugmentation treatments 29 and 30 (culture B is the DHM-1 enrichment 
culture developed by Shan et al. (9) 
 
The recommended dose was based on a study by Shan et al. (7):  960 mg/L of corn syrup 
as COD was added per 500 mg/L of CF, or ~1.9 mg corn syrup as COD per mg CF.  This 
is equivalent to 2.0 mg CS/mg CF.  Based on an average measured CF level in the low 
concentration microcosms of 1.06 µmol/bottle (2.0 mg/L), the resulting dose of corn 
syrup is: 
 








= 5.1 𝑚𝑚𝑚𝑚/𝐿𝐿  
 
 
The same dose is recommended for SRS, i.e., 1.9 mg as COD per mg CF.  We measured 
the COD of the SRS and it was close to what was expected based on an average 
composition for vegetable oil.  The reported concentration of vegetable oil (VO) in SRS 
is 57% and the average composition is C56H100O6, resulting in 2.88 mg COD/mg VO.  
Based on an average measured CF level in the low concentration microcosms of 1.06 
µmol/bottle (2.0 mg/L), the resulting dose of SRS is: 
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�1.9 𝑚𝑚𝑚𝑚 𝑉𝑉𝑉𝑉 𝐶𝐶𝑉𝑉𝐶𝐶𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶 � �
1 𝑚𝑚𝑚𝑚 𝑉𝑉𝑉𝑉












= 2.9 𝑚𝑚𝑚𝑚/𝐿𝐿  
 
 
CFC-11 and CT are also present at each location.  Shan et al. (2) obtained transformation 
of ~15 mg/L CT and 25 mg/L CFC-11 by adding 960 mg/L of corn syrup as COD.  
 
We started with a CS dose of 5.1 mg/L and an SRS dose of 2.9 mg/L.  Since this did not 
achieve complete removal of the halomethanes, additional doses at the same 
concentration were made.   
 
The average measured CF level in the high concentration microcosms is 14.9 µmol/bottle 
(28 mg/L).  Consequently, the CS and VO doses should be higher by a factor of 14.9/1.06, 
or 14.1X.  This equates to an initial CS dose of 71 mg/L and an SRS dose of 41 mg/L.  
Since this did not achieve complete removal of the halomethanes within several weeks, 
additional doses at the same concentration were made. 
 
The site groundwater has a significant concentration of sulfate, especially in the 
upgradient location.  The dose used in the microcosm study by Shan et al. (7) was 
performed with groundwater from the Honeywell site and therefore factors in the 
presence of sulfate.  Repeat doses of CS were required in the previous microcosm study, 
to satisfy a portion of the demand for sulfate reduction.   
 
Shan et al. (7, 9) used 0.03 mol B12 per mol of CF.  A subsequent study demonstrated that 
one half this dose yielded nearly the same maximum rate of CF biodegradation.  
Therefore, we initially used a dose of 0.015 mol B12 per mol of CF.  For the low 
concentration microcosms, the required dose was therefore:   
 
(0.015 µmol B12/µmol CF)*(1.09 µmol CF/bottle)/(0.050 L/bottle) = 0.33 µM  
 
For the high concentration microcosms, the initial dose was 14.1 times higher, or 4.6 µM.   
 
The bioaugmentation dose with enrichment culture DHM-1 (containing ~200 mg/L) was 
1% by volume, or 0.5 mL per bottle (Shan et al., 2014), for both the low and high 




Lactate and SRS were used as the electron donors for halorespiration of CF to DCM.  
This applied to: 
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• Set II, treatments 4, 9 and 10 
• Set III, treatments 12, 17, and 18 
• Set V, treatments 22, 27, and 28  
 
Reduction of 1 mol of CF to DCM requires 1 mol of H2.  The expected hydrogen yield 
for lactate is 2 mmol per mmol fermented: 
 
C3H5O3- + H2O  CH3COO- + CO2 + 2H2 
 
The acetate that is formed is not typically fermented further, so it will not be considered 
in the hydrogen yield.  Therefore, the stoichiometry is 0.5 mmol lactate per mmol of 
CF.  Incorporating a safety factor of 5, the required lactate dose is: 
 
(0.5 mmol lactate/mmol CF)*(5 safety factor)*(90 mg lactate/mmol) *(1 mmol 
CF/119.38 mg) =1.9 mg lactate/mg CF.   
 
Based on an average measured CF level in the low concentration microcosms of 1.06 
µmol/bottle (2.0 mg/L), the resulting dose of lactate is: 
 








= 4.8 𝑚𝑚𝑚𝑚/𝐿𝐿  
Note that the lactate is available as a 60% syrup of sodium lactate, so that the dose of 
syrup will be (4.8)*(112/90)/0.6 = 10 mg/L.   
 
Since this did not achieve complete removal of the halomethanes within several weeks, 
additional doses were made.   
 
The expected hydrogen yield for the vegetable oil in SRS is 44 mmol per mmol 
fermented: 
 
C56H100O6 + 50H2O  28CH3COOH + 44H2 
 
The acetate that is formed is not typically fermented further, so it will not be considered 
in the hydrogen yield.  Therefore, the stoichiometry is 0.0227 mmol vegetable oil per 
mmol of CF.  Incorporating a safety factor of 5, the required SRS dose is: 
 
(0.0227 mmol vegetable oil/mmol CF)*(5 safety factor)*(868 mg vegetable oil/mmol*(1 
mmol CF/119.38 mg) =0.83 mg vegetable oil/mg CF.  Since SRS contains 57% VO, the 
dose is 1.5 mg SRS/mg CF.     
 
Based on an average measured CF level in the low concentration microcosms of 1.06 
µmol/bottle (2.0 mg/L), the resulting dose of SRS is: 
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=  3.8 𝑚𝑚𝑚𝑚/𝐿𝐿 
 
 
We started with an SRS dose of 3.8 mg/L.  Since this does did not achieve complete 
removal of the halomethanes within several weeks, additional doses were made.   
 
The average measured CF level in the high concentration microcosms is 14.9 µmol/bottle 
(28 mg/L).  Consequently, the lactate and VO doses should be higher by a factor of 
14.9/1.06, or 14.1X.  This equates to an initial lactate dose of 67 mg/L and an SRS dose 
of 53 mg/L.  Since dose did not achieve complete removal of the halomethanes within 
several weeks, additional doses were made. 
 
The initial dose does not take into account the donor demand for sulfate reduction.  
Sulfate will be monitored to determine if sulfidogens are competing for lactate and VO; 
more will be added if this occurs.  The initial dose needed to satisfy the substrate demand 
to remove CFC-11 and other halomethanes such as CT was not included in the above 
calculation; their removal occurs only via cometabolism.   
 
The bioaugmentation dose with KB-1© Plus was 1% by volume, or 0.5 mL per bottle, for 
both the low and high concentration microcosms.  Repeat inoculations were also made in 




Shan, H., H. D. Kurtz Jr., and D. L. Freedman. 2010a. Evaluation of strategies 
for anaerobic bioremediation of high concentrations of halomethanes. Wat. Res. 
44:1317-1328. 
Shan, H., H. D. Kurtz, Jr., N. Mykytczuk, J. T. Trevors, and D. L. Freedman. 
2010b. Anaerobic biotransformation of high concentrations of chloroform by an 
enrichment culture and two bacterial isolates. Appl. Environ. Microbiol. 76:6463-
6469. 
Shan, H., R. Yu, H. Wang, P. Jacobs, and D. L. Freedman.  2014.  
Biodegradation of high concentrations of halomethanes by a fermentative 
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The starting point for the experimental design of the abiotic experiments is the amount of 
sodium dithionite (NaD).  Gorby et al. (1994) (21)added 40 mg of NaD to 10 mL of 
Hanford GW; we scaled this amount up to 50 mL, or 0.20 g NaD.  Since the microcosms 
will have 20 g of soil, this is a 1% w/w dose.  To achieve this dose, we plan to add 1.50 
mL of a stock solution that contains 150 g/L of 89% NaD powder.  
 
The following half reaction applies to NaD: 
 
S2O42- + 4H2O    2SO42- + 8H+ + 6e- 
 
Consequently, adding 0.2 g NaD per bottle will provide 6.89 meq.   
 
We don’t know how the dose used by Gorby et al. (1994)(21) relates to the 
concentrations and soil type in this study.  Nevertheless, if the proposed dose elicits no 




The dose of CaSx was calculated to provide the same electron equivalents per bottle, i.e., 
6.89 meq.  Assuming each mole of sulfide in CaSx is oxidized to sulfate, the yield is 8 
equivalents per mole.   
 
The solution of CaSx that we received contains 22.5% S; the solution itself is 29% CaSx 
and its density is 1.27 g/mL.  Using this information, to achieve 6.89 meq per bottle will 
require an addition of 0.33 mL of solution.   
 
If the dose provided does not result in a rapid response, more will be added.  For example, 
if the sulfide is oxidized to sulfur instead of sulfate, the electron yield will be 25% of 




To achieve 6.89 meq per bottle of ZVI will require addition of 0.38 g, based on 1 
equivalent per mole of Feo.  This is a higher dose than the 1% (w/w) we have used in the 
past.  If removal of the halomethanes occurs at a very high rate, we can consider 
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Titanium Citrate + B12 
 
To provide 6.89 meq per bottle of Ti would require and unrealistic amount of a solution 
of titanium citrate if one assumes that Ti serves as the electron donor.  Our expectation is 
that Ti is serving as an electron shuttle rather than a donor; the actual donor is the citrate 
(which also chelates the titanium), along with glucose.  We based our calculation for the 
amount to add on citrate as the electron donor: 
 
C6H8O7 + 5H2O   6CO2 + 18H+ + 18e- 
 
Following the protocol for preparation of titanium citrate descried by Zhender and 
Wuhrmann (1976)(32), the concentration is 0.20 mmol citrate per mL, or 3.6 meq/mL.  
Consequently, to provide 6.89 meq per bottle will require 1.9 mL of the Zhender and 
Wuhrmann (1976) solution.   
 
The stoichiometry of B12 and glucose addition will be the same as that recommended by 
Mower:  4 mmol titanium:3 mg B12:1000 mg glucose.  The concentration of titanium in 
the solution described by Zhender and Wuhrmann (1976)(32) is 0.156 mM (or 0.156 
µmol/mL).  The B12 needed is 0.75 µg/µmol of Ti, so the concentration of B12 we will 
add to the titanium citrate solution will be 0.117 µg/mL.  Adding 1.9 mL will result in 
0.222 µg of B12, or 0.00016 µmol per bottle.  This is much lower than the doses we have 
added to the live bottles (0.236 µmol).  The concentration of glucose is 25 mg/mmol of 
titanium, so the concentration added to the titanium citrate will be 3.9 mg/L.  If we do not 
observe rapid activity, we will increase the dose of titanium citrate and/or B12 and 
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Appendix C 
KB-1© PLUS CULTURE COMPOUNDS ADDITION 
 
CF saturated water  
 
CF saturated water was injected into each 100 mL KB-1© Plus culture to reach CF 
concentration of 20 mg/L, which is approximately 0.151 mmol CF/L. The total amount of 
CF was calculated on basis of Henry’s Law: 




∗ 100 𝑚𝑚𝐿𝐿 ∗
𝐿𝐿
1000 𝑚𝑚𝐿𝐿







= 2.16 𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶 
To deliver 1.945 mg CF with CF saturated water (8.000 mg CF/mL) (31), the volume of 
addition was determined as below: 
V = 2.16 𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶 ∗
𝑚𝑚𝐿𝐿
8.000 𝑚𝑚𝑚𝑚
= 0.27 𝑚𝑚𝐿𝐿 ≈ 0.25 𝑚𝑚𝐿𝐿 
 
CF saturated water was also injected into a 2 L bottle which contain 1 L KB-1© Plus 
culture to reach CF concentration of 30 mg/L. The volume of CF saturated water delivery 
was calculated as below: 




∗ 1000 𝑚𝑚𝐿𝐿 ∗
𝐿𝐿
1000 𝑚𝑚𝐿𝐿







= 34.02 𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶 
V = 34.02 𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶 ∗
𝑚𝑚𝐿𝐿
8.000 𝑚𝑚𝑚𝑚
= 4.250 𝑚𝑚𝐿𝐿 ≈ 4.4 𝑚𝑚𝐿𝐿 
DCM saturated water 
Based on halorespiration pathway, DCM was transformed from CF at 1:1 molar ratio (15). 
DCM saturated water was injected into each 100 mL KB-1© Plus culture to reach DCM 
concentration of 12.72 mg/L, which is approximately 0.150 mmol DCM/L. The total 
amount of CF was calculated on basis of Henry’s Law: 
 




∗ 100 𝑚𝑚𝐿𝐿 ∗
𝐿𝐿
1000 𝑚𝑚𝐿𝐿
+ 0.0806 ∗ 12.72 
𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶𝑀𝑀
𝐿𝐿
∗ 60 𝑚𝑚𝐿𝐿 ∗
𝐿𝐿
1000 𝑚𝑚𝐿𝐿
= 1. 33𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶𝑀𝑀 
To deliver 1.33 mg DCM with DCM saturated water (20 mg DCM/mL)(31), the volume 
of addition was determined as below: 
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V = 1.33 𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶𝑀𝑀 ∗
𝑚𝑚𝐿𝐿
20 𝑚𝑚𝑚𝑚
= 0.0665 𝑚𝑚𝐿𝐿 ≈ 0.07 𝑚𝑚𝐿𝐿 = 70 𝜇𝜇𝐿𝐿 
 
Sodium lactate solution  
 
Sodium lactate solution was added into KB-1© Plus culture supplying electron equivalent 
to transform CF to DCM. DCM fermentation demands no other electron donor but 
itself(15). According Appendix D, lactate dosage is 0.5 mmol sodium lactate per mmol 
CF being transformed to DCM. Each 100 mL KB-1© Plus culture contained 1.94 mg CF, 
which is 1.63*10-2 mmol CF. The mole of sodium lactate required in each 100 mL KB-1© 
Plus culture was calculated as below: 







1 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑠𝑠𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏
1 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏
∗
112.06 𝑚𝑚𝑚𝑚 𝑠𝑠𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏
𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚
= 1.01 𝑚𝑚𝑚𝑚 𝑠𝑠𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏 
 
The volume of 650 g sodium lactate syrup/L solution was calculated as below: 
1.01 𝑚𝑚𝑚𝑚 𝑠𝑠𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏 ∗
𝑚𝑚𝐿𝐿
650 𝑚𝑚𝑚𝑚 𝑠𝑠𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
∗
1 𝑚𝑚𝑚𝑚 𝑠𝑠𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
0.6 𝑚𝑚𝑚𝑚 𝑠𝑠𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑚𝑚 𝑚𝑚𝐿𝐿𝐿𝐿𝑏𝑏𝐿𝐿𝑏𝑏𝑏𝑏
∗ 10 (𝑠𝑠𝐿𝐿𝑠𝑠𝑏𝑏𝑏𝑏𝑠𝑠 𝑠𝑠𝐿𝐿𝐿𝐿𝑏𝑏𝑚𝑚𝑠𝑠) = 0.026 𝑚𝑚𝐿𝐿 
≈ 0.025 𝑚𝑚𝐿𝐿 = 25 𝜇𝜇𝐿𝐿 
 
BES addition 
BES was added to reach a concentration of 50 mM for the purpose of inhibiting 
methanogenesis (15). In each 100 mL KB-1© Plus culture, the BES mass addition was 
calculated as below: 
 
𝑀𝑀 = 50 
𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚
𝐿𝐿





















14C-labeled volatile compounds were analyzed with a GC/combustion technique.  
Headspace samples were injected onto the 1% SP-1000 on 60/80 Carbopak B column and 
the well-separated compounds were routed to a catalytic combustion tube, where they 
were oxidized at 800°C to CO2.  As fractions eluted from the combustion tube, they were 
trapped in NaOH (0.5 M) and added to liquid scintillation cocktail. The 14C activity in a 
fraction was converted to 14C-activity per bottle based on the volumes of the sample, 
headspace, and liquid, as well as Henry’s law constant for each compound.   
 14CO2 and 14C-labeled nonvolatile compounds were measured after analysis of 
the 14C-labeled volatile compounds was completed.  Samples of the liquid phase (10 mL) 
were transferred to a test tube that was connected to a second test tube containing NaOH 
(0.5 M).  Nitrogen gas was sparged into the first tube and passed into the second.  The pH 
in the first tube was then lowered with HCl, to allow for stripping of CO2, which was 
trapped in the second tube.  The term given to the liquid remaining in the first tube after 
acidic sparging is nonstrippable residue (NSR).  The radioactivity of NSR was 
determined by counting the level of 14C activity of 2 mL of NSR sample that directly 
added into 15 mL of scintillation cocktail. The rest of liquid from the stripping chamber 
and the absorption stripping chamber were collected into a 20 mL scintillation vial and a 
15 mL plastic centrifuge tube.  
 The following test was conducted to evaluate the presumption that the absorption 
chamber contained 14CO2 and no other compounds that are soluble at high pH.  Barium 
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hydroxide (1.54 g) was added to samples from the adsorption chamber (8 mL), shaken 
with a constant speed vortex mixer that obtained from VWR.  The amount of Ba(OH)2 
added was in considerable excess of the amount needed to precipitate all of the 
carbonates present as highly insoluble BaCO3.  The contents were then centrifuged at 
2,500 rpm for 20 minutes and 2 mL of centrate was counted in liquid scintillation 
cocktail.  Overall, the average amount of 14C present in the centrate was 0.4% ± 0.33 % 
of the total 14C radioactivity in the absorption chamber.  This indicated that the vast 
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Appendix E 
ELECTRON EQUIVALENT DEMAND  
 Electron equivalent demand in each microcosms was calculated based on equation 
below: 




= 𝐵𝐵𝑚𝑚𝑏𝑏𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑒𝑒𝐿𝐿𝑚𝑚𝑏𝑏𝐸𝐸𝑏𝑏 𝑠𝑠𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑠𝑠𝑏𝑏𝑠𝑠 𝑠𝑠𝑚𝑚𝑠𝑠 𝐿𝐿𝑚𝑚𝑚𝑚𝑠𝑠𝑚𝑚𝑏𝑏𝑏𝑏𝑏𝑏 𝑠𝑠𝑏𝑏𝑠𝑠𝑠𝑠𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑚𝑚𝑠𝑠 𝐶𝐶𝑉𝑉42− 𝑠𝑠𝐸𝐸 𝑚𝑚𝑠𝑠𝐿𝐿𝑠𝑠𝑚𝑚𝐿𝐿𝑚𝑚𝑠𝑠𝑚𝑚
+ 𝐵𝐵𝑚𝑚𝑏𝑏𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑒𝑒𝐿𝐿𝑚𝑚𝑏𝑏𝐸𝐸𝑏𝑏 𝑚𝑚𝑠𝑠 𝑏𝑏𝑚𝑚𝑏𝑏𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑠𝑠𝑚𝑚𝐸𝐸𝑚𝑚𝑠𝑠 𝑏𝑏ℎ𝐿𝐿𝑏𝑏 𝑠𝑠𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑠𝑠𝑏𝑏𝑠𝑠 𝑠𝑠𝑚𝑚𝑠𝑠 𝐿𝐿𝑚𝑚𝑚𝑚𝑠𝑠𝑚𝑚𝑏𝑏𝑏𝑏𝑏𝑏 𝐶𝐶𝐶𝐶 𝑠𝑠𝑏𝑏𝑚𝑚𝑚𝑚𝑒𝑒𝐿𝐿𝑚𝑚 𝑏𝑏𝐿𝐿𝑠𝑠𝑏𝑏𝑠𝑠 𝑚𝑚𝐸𝐸 𝑠𝑠𝑚𝑚𝑠𝑠𝐿𝐿𝑚𝑚𝑏𝑏 
 Electron equivalent required for complete 𝐶𝐶𝑉𝑉42− removal was based on the redox 
reaction below:  
8𝐻𝐻+ + 𝐶𝐶𝑉𝑉42− + 8 𝑏𝑏− → 𝐶𝐶2− + 4 𝐻𝐻2𝑉𝑉 
 In this redox reaction, 8 eeq of electron equivalent was required for each mole of 
𝐶𝐶𝑉𝑉42− reduction. Therefore, the electron equivalent required was calculated as followed: 
𝐵𝐵𝑚𝑚𝑏𝑏𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑒𝑒𝐿𝐿𝑚𝑚𝑏𝑏𝐸𝐸𝑏𝑏 𝑠𝑠𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑠𝑠𝑏𝑏𝑠𝑠 𝑠𝑠𝑚𝑚𝑠𝑠 𝐿𝐿𝑚𝑚𝑚𝑚𝑠𝑠𝑚𝑚𝑏𝑏𝑏𝑏𝑏𝑏 𝑠𝑠𝑏𝑏𝑠𝑠𝑠𝑠𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑚𝑚𝑠𝑠 𝐶𝐶𝑉𝑉42− 𝑠𝑠𝐸𝐸 𝑚𝑚𝑠𝑠𝐿𝐿𝑠𝑠𝑚𝑚𝐿𝐿𝑚𝑚𝑠𝑠𝑚𝑚
=  










0.05 𝐿𝐿 𝑚𝑚𝑠𝑠𝑚𝑚𝑠𝑠𝐸𝐸𝑠𝑠𝑔𝑔𝐿𝐿𝑏𝑏𝑏𝑏𝑠𝑠 
𝑏𝑏𝑚𝑚𝑏𝑏𝑏𝑏𝑚𝑚𝑏𝑏 𝑚𝑚𝑠𝑠 𝑚𝑚𝑠𝑠𝐿𝐿𝑠𝑠𝑚𝑚𝐿𝐿𝑚𝑚𝑠𝑠𝑚𝑚𝑠𝑠
 
 Sulfate concentrations of low CF groundwater sample (from sampling well AS-
MW-65) and high CF groundwater sample (from sampling well AS-MW-63)  were 3,107 
mg/L and 1,934 mg/L. Substitute the sulfate concentration in the equation above, and 
calculated the electron equivalent required for compelete reduction of 𝐶𝐶𝑉𝑉42− in 
microcosm: results are shown below: 










0.05 𝐿𝐿 𝑚𝑚𝑠𝑠𝑚𝑚𝑠𝑠𝐸𝐸𝑠𝑠𝑔𝑔𝐿𝐿𝑏𝑏𝑏𝑏𝑠𝑠 
𝑏𝑏𝑚𝑚𝑏𝑏𝑏𝑏𝑚𝑚𝑏𝑏 𝑚𝑚𝑠𝑠 𝑚𝑚𝑠𝑠𝐿𝐿𝑠𝑠𝑚𝑚𝐿𝐿𝑚𝑚𝑠𝑠𝑚𝑚𝑠𝑠
= 12.9 𝑚𝑚𝑏𝑏𝑒𝑒/𝑏𝑏𝑚𝑚𝑏𝑏𝑏𝑏𝑚𝑚𝑏𝑏 










0.05 𝐿𝐿 𝑚𝑚𝑠𝑠𝑚𝑚𝑠𝑠𝐸𝐸𝑠𝑠𝑔𝑔𝐿𝐿𝑏𝑏𝑏𝑏𝑠𝑠 
𝑏𝑏𝑚𝑚𝑏𝑏𝑏𝑏𝑚𝑚𝑏𝑏 𝑚𝑚𝑠𝑠 𝑚𝑚𝑠𝑠𝐿𝐿𝑠𝑠𝑚𝑚𝐿𝐿𝑚𝑚𝑠𝑠𝑚𝑚𝑠𝑠
= 8.06 𝑚𝑚𝑏𝑏𝑒𝑒/𝑏𝑏𝑚𝑚𝑏𝑏𝑏𝑏𝑚𝑚𝑏𝑏 




 Electron donor dosage that required for complete CF removal is shown in table 
below: 
Table E.1 Electron donor dosage that required for complete CF removal in microcosm 
Dose (mg donor/mg CF)  
  
Cometabolism  
Treatment # that applied  
CS 2 5, 6, 13, 14, 23, 24, 29  
SRS  0.66 8, 16, 26, 30  
Metabolism  
  
Lac 1.9 4, 9, 12, 17, 22, 27  
SRS 0.83 7, 15, 25, 28  
 
 Representative amounts of CF in each microcosms were 1.06 μmol/bottle, and 
14.9 μmol/bottle for low CF microcosms and high CF microcosms, respectively. The 
representative mass of CF in each microcosms were calculated below: 









= 0.127 𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶 









= 1.78 𝑚𝑚𝑚𝑚 𝐶𝐶𝐶𝐶 
 Electron donor equivalent required for complete CF removal was calculated based 
on equation as below: 
𝐵𝐵𝑚𝑚𝑏𝑏𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑒𝑒𝐿𝐿𝑚𝑚𝑏𝑏𝐸𝐸𝑏𝑏 𝑚𝑚𝑠𝑠 𝑏𝑏𝑚𝑚𝑏𝑏𝐿𝐿𝑏𝑏𝑠𝑠𝑚𝑚𝐸𝐸 𝑠𝑠𝑚𝑚𝐸𝐸𝑚𝑚𝑠𝑠 𝑏𝑏ℎ𝐿𝐿𝑏𝑏 𝑠𝑠𝑏𝑏𝑒𝑒𝑠𝑠𝑠𝑠𝑠𝑠𝑏𝑏𝑠𝑠 𝑠𝑠𝑚𝑚𝑠𝑠 𝐿𝐿𝑚𝑚𝑚𝑚𝑠𝑠𝑚𝑚𝑏𝑏𝑏𝑏𝑏𝑏 𝐶𝐶𝐶𝐶 𝑠𝑠𝑏𝑏𝑚𝑚𝑚𝑚𝑒𝑒𝐿𝐿𝑚𝑚 𝑏𝑏𝐿𝐿𝑠𝑠𝑏𝑏𝑠𝑠 𝑚𝑚𝐸𝐸 𝑠𝑠𝑚𝑚𝑠𝑠𝐿𝐿𝑚𝑚𝑏𝑏
= Representative mass of CF in microcosms (mg)
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 Electron equivalent of donor was calculated based on complete oxidation , that is 
to say mineralization, of each type of electron donor. Electron equivalent and molecular 
weight of donor is listed in the table below: 






Corn Syrup 180 24 
Sodium 
Lactate 90 12 
Vegetable Oil 868 312 
 
 Calculation results of electron donor equivalent required for complete CF removal 
was showen in table below: 
Table E.3 Electron equivalent demand for CF compete removal in microcosms (unit: meq/bottle) 
Co-metabolism Low CF Microcosms High CF microcosms Treatment # that applied 
CS  3.37E-02 4.74E-01 5, 6, 13, 14, 23, 24, 29 
Vegetable oil  3.00E-02 4.22E-01 8, 16, 26, 30 
Metabolism 
   Lac  3.21E-02 4.51E-01 4, 9, 12, 17, 22, 27 
Vegetable oil  3.78E-02 5.31E-01 7, 15, 25, 28 
 
 Apply the electron equivalent demand calculation equation and get the total 
amount of electron equivalent demand as shown below:  
Table E.4 Electron equivalent demand in microcosms (unit: meq/bottle) 
Co-metabolism Low CF Microcosms High CF microcosms Treatment # that applied 
CS  13.0 8.53 #5, 6, 13, 14, 23, 24, 29 
Vegetable oil  13.0 8.48 #8, 16, 26, 30 
Metabolism 
   Lac  13.0 8.51 #4, 9, 12, 17, 22, 27 
Vegetable oil  13.0 8.59 #7, 15, 25, 28 
 
As far as I can see, sulfate removal required the majority of electron equivalent 
demand in microcosms. 
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